Adult Medicine PRN

Promotions

• Kajal Patel: PGY1 Pharmacy Residency Site Coordinator, Atlantic Health System-Overlook Medical Center.
• Jennifer Szwak: PGY1 Residency Program Director, The Johns Hopkins Hospital.

 Awards

• Jennifer Szwak: 2024 Preceptor of the Year Award, American Association of Colleges of Pharmacy.

 Publications

• Clements JN, McClendon K, Borchert J, Ciapala SRL, Courtney LA, Cummings J, Fallon JM, Fritz MK, Gibson CM, Isaacs AN, Israel EN, Johnson P, Krauter A, et al. Teaching experiences in pharmacy residency. J Am Coll Clin Pharm. 2025;8(1):62-69. https://doi.org/10.1002/jac5.2066
• Gibson CM, Beard MM, Escano AK, et al. Metolazone versus chlorothiazide in acute heart failure patients with diuretic resistance and renal dysfunction: a retrospective cohort study. J Cardiovasc Pharmacol. 2024;84(4):451-456. https://doi.org/10.1097/FJC.0000000000001623
• Gibson CM, Howard ML, Haight RC. Validation of an instrument to assess student pharmacist self-authorship. Curr Pharm Teach Learn. 2025;17(2):102264. https://doi.org/10.1016/j.cptl.2024.102264
• Gibson CM, Lacroix M, Hevener KE. Professional pharmacy fraternities as a mechanism for co-curricular learning: a qualitative analysis of two organizations. Am J Pharm Educ. 2024;88(8):101249. https://doi.org/10.1016/j.ajpe.2024.101249
• Ahmed AF, Zachariah S, Ismail AH, Gibson CM. Variation among venous thromboembolism risk assessment tools for post-cesarean patients: a retrospective cohort study. Blood Coagul Fibrinolysis. 2024;35(8):357-361. https://doi.org/10.1097/MBC.0000000000001325
• Fox J, Bond R, Matulewicz A, Gibson CM, Sanders K, Dixon DL. Exploring the impact of generation status on pharmacy admissions: a comparative study of first-generation and continuing-generation college students. Am J Pharm Educ. 2024;88(9):101258. https://doi.org/10.1016/j.ajpe.2024.101258
• Hanners EK, Thambi M, Soni HP, et al. The effects of multimodal versus opioid-only analgesia on pain control and opioid exposure for inpatient acute pancreatitis: a retrospective cohort study. Am J Health Syst Pharm. 2024 Nov 10. https://doi.org/10.1093/ajhp/zxae335
• Parsons KA, Barrickman A, Dupree LH, Begley K, Hong L, et al. Current state of APPE-readiness assessments in schools or colleges of pharmacy. Curr Pharm Teach Learn. 2024;17(3):102241. https://doi.org/10.1016/j.cptl.2024.102241
• Phan P, Hong LT. Comparison of direct oral anticoagulants for treatment of cerebral venous thrombosis—a retrospective cohort study. Clin Appl Thromb Hemost. 2025;31:10760296251316869. https://doi.org/10.1177/10760296251316869
• Thai T, Hong L, Hauschild C, Iso T. Comparison of sodium zirconium cyclosilicate and sodium polystyrene sulfonate in the treatment of acute hyperkalaemia. Eur J Hosp Pharm. 2024 Dec 20. [Epub ahead of print] https://doi.org/10.1136/ejhpharm-2024-004374
• Hopkins AJ, Chau T, Pullinger B, et al. Evaluation of unfractionated heparin therapy for venous thromboembolism using adjusted body weight in elderly or higher weight patients. J Thromb Thrombolysis. 2024 Dec 4. [Epub ahead of print] https://doi.org/10.1007/s11239-024-03060-4
• Mercer KJ, Craddock KE, Patel SV, Knoebel RW, Soni HP, Lourenco LM, Bastow SS, Szwak JA. Implementation of debriefing services for pharmacy residents in a 24-hour, in-house clinical pharmacy on-call program: a pilot study. J Pharm Pract. 2024;37(4):822-829. https://doi.org/10.1177/08971900231182776
• Evoy KE, Balli M, Carris NW, Castelli G, Isch JL, Meredith AH, Mohammad I, Philbrick A, Prasad-Reddy L, Riccio KKC, Schumacher C, Soric MM, eds. ACCP Ambulatory Care Pharmacist’s Survival Guide. 5th ed. American College of Clinical Pharmacy; 2024.
• Steuber TD, Trujillo D, Kleppinger EL, et al. Impact of curricular content reduction on student reported mental and physical health. Am J Pharm Educ. 2025. In press. http://doi.org/10.1016/j.ajpe.2025.101367
• Irwin AN, Marciniak MW, Awad R, Cadiz CL, Cook SG, Hebert SMC, Lee JY, Orth LE, Szwak JA. Interprofessional team-based care in the community pharmacy setting: a summary of existing models and best practice recommendations. J Am Coll Clin Pharm. 2024;7(10):1056-1067. https://doi.org/10.1002/jac5.2021
• Miranda AC, Cornelio CK, Tran BAC, Fernandez J. Sotatercept: a first-in-class activin signaling inhibitor for pulmonary arterial hypertension. J Pharm Tech. 2025. https://doi.org/10.1177/87551225251317957

 Presentations

• Hailey Soni: Perspective pearls: navigating the residency program tsunami. Presented at: ASHP Midyear Clinical Meeting; December 2024; New Orleans, LA.
• Taylor Steuber: Practice what you teach: innovating teaching methods—unique methods for teaching critical literature evaluation skills. Presented at: American College of Clinical Pharmacy Annual Meeting; October 2024; Phoenix, AZ.

 New ACCP Fellows

• Caitlyn Gibson
• Taylor Steuber

 Other Notable Achievements

• Andy Stone: Transitioning into the PGY1 Pharmacy/PGY2 Pharmacotherapy Residency Program Director starting July 2025 at The Ohio State University Wexner Medical Center.

Ambulatory Care PRN

Promotions

• Shelby Tungate Lopez: Assistant Professor, UNC Eshelman School of Pharmacy.

Awards

• Abigail Elmes-Patel: Best Poster, Education and Training Practice and Research Network, 2024 ACCP Annual Meeting.
• Alexis E. Horace: Dean’s Award for Excellence in Clinical Care, University of Louisiana at Monroe College of Pharmacy.
• Kimmy Nguyen: Preceptor of the Year, Pennsylvania Pharmacists Association; Colonel’s Distinguished Employee Award, Wilkes University.
• Magaly Rodriguez de Bittner: Maryland Top 100 Women, The Maryland Daily Record.

Publications

• Elmes-Patel AT, Allen SA, Djuric Kachlic M, et al. Preceptor perspectives on entrustable professional activity–based assessment in advanced pharmacy practice experiences. Am J Pharm Educ. 2024;88(12):101332. https://doi.org/10.1016/j.ajpe.2024.101332
• Taylor DR, Schwartz A, Elmes-Patel AT, Marty AP, Hennus MP. Monitoring and evaluating EPAs and EPA frameworks. In: ten Cate O, Burch VC, Chen C, Chou FC, Hennus MP, eds. Entrustable Professional Activities and Entrustment Decision-Making in Health Professions Education. Ubiquity Press; 2024.
• Evoy KE, Balli M, Carris NW, Castelli G, Isch JL, Meredith AH, Mohammad I, Philbrick A, Prasad-Reddy L, Riccio KKC, Schumacher C, Soric MM, eds. ACCP Ambulatory Care Pharmacist’s Survival Guide. 5th ed. American College of Clinical Pharmacy; 2024.
• Finks SW, Benavides D, Martin AG, Carmon AS. Real-world observations of using compounded GLP-1 ± GIP agonists within a clinical pharmacist–managed cardiometabolic clinic. J Am Coll Clin Pharm. 2025;8:91-97. https://doi.org/10.1002/jac5.2071
• Horace AE, Atawodi-Alhassan O. Assessment of knowledge and behaviors of an opioid overdose education and naloxone distribution program during the coronavirus disease 2019 pandemic. Harm Reduct J. 2024 February 7. [Epub ahead of print] https://doi.org/10.21203/rs.3.rs-3922269/v1
• Massmann A, Heukelom JV, Weaver M, et al. Evaluation of pharmacogenetic automated clinical decision support for clopidogrel. Pharmacogenomics. 2024;25(8-9):391-399. https://doi.org/10.1080/14622416.2024.2394014
• Massmann A, Petry N, Mills S, Adjekum A, Van Heukelom J. Impact of using dosing criteria to refine pharmacogenomic clinical decision support for tricyclic antidepressants. Am J Health Syst Pharm. 2024 November 9. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae337
• Brown JT, Goldwire M, Massmann A, et al. The impact of pharmacogenomics on a pharmacy and therapeutic committee’s formulary system management: an opinion of the Pharmacokinetics/Pharmacodynamics/Pharmacogenomics Practice and Research Network for the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2025;8(1):52-61. https://doi.org/10.1002/jac5.2057
• Chow TG, McDanel DL, Turner NA, Copaesco AM. Non-allergist delabeling—should penicillin allergy delabeling only be performed by allergists? J Allergy Clin Immunol Pract. 2024 December 24. [Epub ahead of print] https://doi.org/10.1016/j.jaip.2024.11.028
• Neeb C, McQuade B, Lesondak L, et al. Integration of a community opioid treatment program into a federally qualified health center. J Addict Med. 2024;18(6):663-669. https://doi.org/10.1097/ADM.0000000000001336
• O’Connell MB, DeLellis TM. Musculoskeletal and connective tissue disorders. In: Hutchinson LC, Sleeper R, eds. Fundamentals of Geriatric Pharmacotherapy. 3rd ed. American Society of Health-System Pharmacists. In press.
• Marcath M, Craig K, O’Connell MB. Impact of reproductive health education seminars on college students’ contraception and safe sex knowledge and behaviors. Pharmacy. 2025;13(2):39. https://doi.org/10.3390/pharmacy13020039
• Riccio KK. Addressing stigmatizing language: training future healthcare professionals within a substance use disorder treatment center. In: Evoy KE, Balli M, Carris NW, et al, eds. ACCP Ambulatory Care Pharmacist’s Survival Guide. 5th ed. American College of Clinical Pharmacy; 2024.
• Riley K. 5 tips/pearls you can use in your practice now: selecting clinical decision support systems to improve efficiency of medication reviews. Pharm Pract+Bus. 2025;12(1).
• Riley K, Yap B, Foley G, Lambe J, Lund S. Impact of a clinical decision support system on identifying drug-related problems and making recommendations to providers during community pharmacist–led medication reviews in Ontario, Canada: a pilot study. J Eval Clin Pract. 2024 Jul 30. [Epub ahead of print] https://doi.org/10.1111/jep.14123
• Sobieraj D, Wheeler K, Salvo MC, Smith M. Prescription for curricular revision: application of design thinking principles. Am J Pharm Educ. 2024;88(12):101325. https://doi.org/10.1016/j.ajpe.2024.101325
• Yik R, Salvo MC. Pharmacy technician education and training: highlighting the partnership among a state pharmacy association, local community college, and healthcare system. Am J Health Syst Pharm. 2025 Jan 2. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae410
• Folz HN, Lee S, Sherrill CH. Student pharmacist counseling performance after hands-on continuous glucose monitoring education: a multi-institutional pragmatic randomized study. Patient Educ Couns. 2025;131:108578. https://doi.org/10.1016/j.pec.2024.108578
• Hwang AY, Sherrill CH. Hypertension. In: American College of Clinical Pharmacy Pharmacotherapy Self-Assessment Program 2025 Book 1 (Cardiology). American College of Clinical Pharmacy; 2025:1-26.
• Litten K, Folz H, Lobkovich A, Sherrill CH, Berlie H. Integrating continuous glucose monitoring into doctor of pharmacy curricula. J Am Coll Clin Pharm. 2025. [Epub ahead of print] https://doi.org/10.1002/jac5.2076
• Silvia RJ, Mohammad I, English C, Bradley BA, Ottney A, Crismon ML. A call to action for ambulatory care pharmacists for the treatment of depression and anxiety in primary care: an opinion paper of the Ambulatory Care and Central Nervous System Practice and Research Networks of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2025 Feb 17. [Epub ahead of print] https://doi.org/10.1002/jac5.70009
• Wilcox L, Van Dril E. Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous glucagon-like peptide-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine: a case report. J Am Pharm Assoc (2003). 2024;64(6):102185. https://doi.org/10.1016/j.japh.2024.102185
• Cutrell S, Zbyrak V, Wheeler SE, Khan R, Bucheit JB. A comprehensive approach to managing people with diabetes and chronic kidney disease. ADCES Pract. 2024;12(6). https://doi.org/10.1177/2633559X241280305

Presentations

• Helen Berlie: Multi-institutional approaches to incorporating continuous glucose monitoring (CGM) into pharmacy education. Presented virtually as a Collaborative AACP Webinar with the Technology in Pharmacy Education and Practice SIG and the Curriculum SIG; 2024; virtual.
• Lauren Cunningham: Possible cholelithiasis linked to liraglutide and safe subsequent use of semaglutide and tirzepatide without cholecystectomy: a case report. Poster presented at: 2024 ACCP Annual Meeting; November 2024; Phoenix, AZ.
• Duncan Dobbins:
  • Emerge first: engage in research & scholarship. Presented at: MCPHS-Boston; January 2025; virtual.
  • Centralized clinical pharmacy services to improve prior authorization management in community practice clinics. Accepted for oral presentation at: HCSRN; April 2025; St. Louis, MO.
  • Keynote Speaker. IPHO Northeast Regional Meeting; March 2025; Albany, NY.
• Abigail Elmes-Patel:
  • On the road to recovery: bringing ambulatory opioid use disorder (OUD) care into the community. Presented at: American Society of Health-System Pharmacists Annual Midyear Meeting; December 2024; New Orleans, LA.
  • Traveling to the bus: a retrospective study of distance traveled to reach a mobile buprenorphine unit. Presented at: Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA) Annual Conference; November 2024; Chicago, IL.
  • Evaluation of a mobile treatment unit: implementation of low-threshold buprenorphine in street-based programming. Presented at: Addiction Health Services Research 2024 Conference; October 2024; San Francisco, CA.
  • The road to recovery: utilization of a mobile outreach unit for medications for opioid use disorder. Presented at: Addiction Health Services Research 2024 Conference; October 2024; San Francisco, CA.
  • Practical solutions for EPAs in competency-based assessment: identifying and addressing challenges with EPA implementation in experiential education. Presented in ACCP EDTR PRN Focus Session (“Do You Trust Me? Entrustable Professional Activities as a Means to Facilitating and Assessing Practice Readiness”); 2024 ACCP Annual Meeting; October 2024; Phoenix, AZ.
• S. Mimi Mukherjee: Impact of a remediation plan in a pharmacotherapeutics course series. Presented at: AACP Pharmacy Education 2024; July 2024; Boston, MA.
• Krystal KC Riccio: Opioid use disorder: update for pharmacists. Presented at: Nevada Society of Health-System Pharmacists/Nevada Pharmacy Alliance Annual Meeting & American Society of Consultant Pharmacists Regional Meeting; 2024; Reno, NV.
• Christie Schumacher:
  • Navigating diabetes medication transitions: strategies for smooth transitions and client support. Presented at: Food & Nutrition Conference & Expo; October 2024; Minneapolis, MN.
  • Using continuous glucose monitoring to advance cardiometabolic kidney care. Presented at:
    • Association of Diabetes Care and Education Specialists Illinois, Indiana, Iowa and Missouri Midwest Connect Annual Diabetes Symposium; November 2024; Normal, IL.
    • Association of Diabetes Care and Education Specialists South Carolina 36th Annual Diabetes Conference: Mission: Possible—Agents for Change; November 2024; Columbia, SC
    • Association of Diabetes Care and Education Specialists 27th Annual Montana Diabetes Professional Conference; October 2024; Fairmont, MT.
  • Use of diabetes medications in the management of non-diabetes conditions. Presented at:
    • Association of Diabetes Care and Education Specialists South Carolina 36th Annual Diabetes Conference: Mission: Possible—Agents for Change; November 2024; Columbia, SC.
    • Association of Diabetes Care and Education Specialists Oregon and Washington Annual Conference: Seas the Days!; October 2024; Seaside, OR.
  • Keeping up with the kidney: updates in the management of chronic kidney disease in people with diabetes. Presented at:
    • Association of Diabetes Care and Education Specialists Maine and New Hampshire Annual Diabetes Conference: Diabetes from Top to Bottom; October 2024; Rochester, NH.
    • Association of Diabetes Care and Education Specialists Chicago Local Networking Group; October 2024; Chicago, IL.
    • Association of Diabetes Care and Education Specialists 27th Annual Montana Diabetes Professional Conference; October 2024; Fairmont, MT.
    • Association of Diabetes Care and Education Specialists Colorado Annual Conference: Diabetes from Head to Toe; September 2024; Denver, CO.
  • Sick days, smart ways: navigating diabetes management during illness. Presented to health care professionals in Utah working with the Association for Utah Community Health; September 2024; virtual.
• Christie Schumacher and Elizabeth Van Dril: Recognize cardiovascular-kidney-metabolic (CKM) syndrome: can we PREVENT it? Presented at: Association of Diabetes Care and Education Specialists Annual Meeting; August 2024; New Orleans, LA.

 New ACCP Fellows

• Krystal KC Riccio
• Jessica Tilton

Other Notable Achievements

• Lauren Cunningham: Appointed Assistant Director, PGY-2 Ambulatory Care Pharmacy Residency Program, University of Illinois Chicago Retzky College of Pharmacy.
• Magaly Rodriguez de Bittner: Will be installed as the APhA President-Elect in Nashville, TN, March 2025.
• Richard Silvia: Fellow, American Association of Psychiatric Pharmacists.

Cardiology PRN

Promotions

• Monique Conway Godfrey: Residency Program Director, PGY2 Cardiology, Duke University Hospital.

Awards

• Caitlin Gibson: Distinguished Investigator of the Year, ACCP Adult Medicine PRN.
• Monique Conway Godfrey: Outstanding Service to Fellow Education, Duke University Hospital—Duke Cardiology Fellowship Program.
• Josh Jacobs: ACCP New Investigator Award, ACCP.
• Sarah Spinler: ACCP Clinical Practice Award, ACCP.
• Robert Talbert: 2024 Legend of Pharmacy Award, University of Texas College of Pharmacy Alumni Association.

Publications

• Baker WL, Moore TE, Baron E, Kittleson M, Parker WF, Jaiswal A. A systematic review of reporting and handling of missing data in observational studies using the UNOS database. J Heart Lung Transplant. 2024 Nov 7. [Epub ahead of print] https://doi.org/10.1016/j.healun.2024.10.023
• Bozkurt B, Ahmad T, Alexander K, Baker WL, et al. HF STATS 2024: heart failure epidemiology and outcome statistics. An updated 2024 report from the Heart Failure Society of America. J Card Fail. 2025;31(1):66-116. https://doi.org/10.1016/j.cardfail.2024.07.001
• Jaiswal A, Baker WL, Pillai A, et al. Corticosteroid use beyond 1-year post heart transplantation is associated with worse outcomes: a contemporary analysis of the ISHLT registry. JHLT Open. 2025;8:100214. https://doi.org/10.1016/j.jhlto.2025.100214
• Jedeon Z, Pillai A, Baker WL, Jaiswal A. Donor pulmonary hemodynamics does not impact recipient outcomes in adult heart transplantation. Int J Cardiol. 2025;420:132747. https://doi.org/10.1016/j.ijcard.2024.132747
• Movahedan M, Ellis UM, Barry AR. Efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with heterozygous familial hypercholesterolemia: a meta-analysis. Am J Cardiovasc Drugs. 2025;25(1):47-55. https://doi.org/10.1007/s40256-024-00682-0
• Peixoto C, Choudhri Y, Francoeur S, McCarthy LM, Fung C, Dowlatshahi D, Lemay G, Barry A, et al. Discontinuation versus continuation of statins: a systematic review. J Am Geriatr Soc. 2024;72(11):3567-3587. https://doi.org/10.1111/jgs.19093
• Siemens R, Pryjma M, Buchkowsky S, Barry AR. Real-world effectiveness of monoclonal antibody inhibitors of PCSK9 in patients with heterozygous familial hypercholesterolemia: a retrospective cohort study. Pharmacotherapy. 2024;44(9):730-737. https://doi.org/10.1002/phar.4609
• Turgeon RD, Ellis UM, Barry AR. Antithrombotic therapy in patients after transcatheter aortic valve implantation: a network meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2024;10(5):454-464. https://doi.org/10.1093/ehjcvp/pvad101
• Cavallari LH, Coons JC. Genetic determinants of response to P2Y₁₂ inhibitors and clinical implications. Interv Cardiol Clin. 2024;13:469-81. https://doi.org/10.1016/j.iccl.2024.06.002
• Cavallari LH, Lee CR, Franchi F, Keeley EC, Rossi JS, Thomas CD, Gong Y, McDonough CW, Starostik P, Al Saeed M, Been L, Kulick N, Malave J, Mulrenin IR, Nguyen AB, Terrell JN, Tillotson G, Beitelshees AL, et al. Precision antiplatelet therapy after percutaneous coronary intervention (Precision PCI) registry—informing optimal antiplatelet strategies to improve outcomes in a diverse, real-world setting. Clin Transl Sci. 2024;17(8):e70004. https://doi.org/10.1111/cts.70004
• Coons JC, Empey PE. Towards consensus recommendations for pharmacogenetics testing. Am J Health Syst Pharm. 2024;12:81:653-654. https://doi.org/10.1093/ajhp/zxae171
• Coons JC, Kliner J, Mathier MA, et al. Medication optimization clinic decreases hospitalizations and mortality for heart failure with reduced ejection fraction patients. Am Heart J Plus. 2024;47:100470. https://doi.org/10.1016/j.ahjo.2024.100470
• Brewer J, Coons JC, Kimber A, et al. Practical management of oral treprostinil therapy in patients with pulmonary arterial hypertension: lessons from ADAPT, EXPEDITE, and expert consensus. Respir Med. 2024;231:107734. https://doi.org/10.1016/j.rmed.2024.107734
• Edwards J, Corey J, Coons JC. Exploring the therapeutic utility of the factor XIa inhibitor asundexian. Am J Health Syst Pharm. 2024;81:1222-1229. https://doi.org/10.1093/ajhp/zxae182
• LeCompte K, Coons JC, Empey PE, Berebrok L. Longitudinal pharmacogenomic learning for student pharmacists. Curr Pharm Teach Learn. 2024;17:102189. https://doi.org/10.1016/j.cptl.2024.102189
• White E, Kane-Gill SL, Jain S, Medico C, Ansani N, Coons JC. Utilizing theoretical domains framework to determine barriers to evidence-based recommendations in non-valvular atrial fibrillation. Ann Pharmacother. 2024 Nov 26. [Epub ahead of print] https://doi.org/10.1177/10600280241298947
• Xu Y, Derington CG, Addo DK, He T, Jacobs JA, Mohanty AF, An J, Cushman WC, Ho PM, Bellows BK, Cohen JB, Bress AP. Trends in initial antihypertensive medication prescribing among >2.8 million veterans newly diagnosed with hypertension, 2000 to 2019. J Am Heart Assoc. 2024;13(20):e036557. https://doi.org/10.1161/JAHA.124.036557
• Finks SW, Benavides D, Martin AG, Carmon AS. Real-world observations of using compounded GLP-1 ± GIP agonists within a clinical pharmacist-managed cardiometabolic clinic. J Am Coll Clin Pharm. 2025;8:91-97. https://doi.org/10.1002/jac5.2071
• Foster EM, Coons JC, Puccio E, et al. Clinical outcomes associated with diltiazem use in heart failure with reduced ejection fraction after implementation of a clinical support system. Ann Pharmacother. 2024;58:1161-1169. https://doi.org/10.1177/10600280241243071
• Gibson CM, Beard MM, Escano AK, Good BL, Potter TG, Truong AM, Van Tassell B. Metolazone vs chlorothiazide in acute heart failure patients with diuretic resistance and renal dysfunction: a retrospective cohort study. J Cardiovasc Pharmacol. 2024;84(4):451-456. https://doi.org/10.1097/FJC.0000000000001623
• Gibson CM, Howard ML, Haight RC. Validation of an instrument to assess student pharmacist self-authorship. Curr Pharm Teach Learn. 2025;17(2):Article 102264. https://doi.org/10.1016/j.cptl.2024.102264
• Gibson CM, Lacroix M, Hevener KE. Professional pharmacy fraternities as a mechanism for co-curricular learning: a qualitative analysis of two organizations. Am J Pharm Educ. 2024;88:Article 101249. https://doi.org/10.1016/j.ajpe.2024.101249
• Ahmed AF, Zachariah S, Ismail AH, Gibson CM. Variation among venous thromboembolism risk assessment tools for post-cesarean patients: a retrospective cohort study. Blood Coagul Fibrinolysis. 2024;35(8):357-361. https://doi.org/10.1097/MBC.0000000000001325
• Clements JN, McClendon K, Borchert J, Ciapala SRL, Courtney LA, Cummings J, Fallon JM, Fritz MK, Gibson CM, et al. ACCP guideline: teaching experiences in pharmacy residency. J Am Coll Clin Pharm. 2025;8:62-69. https://doi.org/10.1002/jac5.2066
• Fox J, Bond R, Matulewicz A, Gibson CM, Sanders K, Dixon DL. Exploring the impact of generation status on pharmacy admissions: a comparative study of first-generation and continuing-generation college students. Am J Pharm Educ. 2024;88:Article 101258. https://doi.org/10.1016/j.ajpe.2024.101258
• Hellenbart EL, Ipema HJ, Rodriguez-Ziccardi MC, Krishna H, DiDomenico RJ. Disease-modifying therapies for amyloid transthyretin cardiomyopathy: current and emerging medications. Pharmacotherapy. 2025;45:122-144. https://doi.org/10.1002/phar.4639
• Jacobs JA, Ayodele I, Bress AP, Greene SJ, Alhanti B, Sterling MR, Pandey A, Derington CG, et al. Social determinants of health and disparities in guideline-directed medical therapy optimization. Circ Heart Fail. 2025;18(1):e012357. https://doi.org/10.1161/CIRCHEARTFAILURE.124.012357
• Jacobs JA, Carter SJ, Bullock G, Carey JR, Pan IZ, O’Brien MS, Zheutlin AR, Kapelios CJ, Raju S, Fang JC, Shah KS, Bress AP. Optimal initial intravenous loop diuretic dosing in acute decompensated heart failure. JACC Adv. 2024;3(10):101250. https://doi.org/10.1016/j.jacadv.2024.101250
• Jacobs JA, Rodgers A, Bellows BK, Hernandez I, Wang N, Derington CG, King JB, Zheutlin AR, Whelton PK, Egan BM, Cushman WC, Bress AP. Use and cost patterns of antihypertensive medications in the United States from 1996 to 2021. Hypertension. 2024;81(11):2307-2317. https://doi.org/10.1161/HYPERTENSIONAHA.124.23509
• Bullock G, Jacobs JA, Carey JR, et al. Patterns of diuretic titration during inpatient management of acute decompensated heart failure. Am Heart J. 2025;282:30-39. https://doi.org/10.1016/j.ahj.2024.12.010
• Zheutlin AR, Jacobs JA, Niforatos JD, Chaitoff A. Prevalence of prescription medication use that can exacerbate heart failure among US adults with heart failure. Pharmacotherapy. 2025 Jan 20. [Epub ahead of print] https://doi.org/10.1002/phar.4648
• Zheutlin AR, Jacobs JA, Stamm B, Royan R. Lipoprotein(a) among normotensive patients and risk of incident hypertension. J Clin Hypertens. 2024;26(11):1313-1317. https://doi.org/10.1111/jch.14904
• Klosko RC, Whitson B, Lampert B, McLaughlin E, Orzel L. Safety of enoxaparin in patients implanted with continuous flow left ventricular assist devices. Artif Organs. 2024 Nov 27. [Epub ahead of print] https://doi.org/10.1111/aor.14908
• Fox LP, Tunehag KR, Nguyen AB, Reed S, Shastri D, Quig N, Stouffer GA, Solander S, Lee CR. Real-world evaluation of CYP2C19 guided antiplatelet therapy in patients undergoing intracranial aneurysm repair. Pharmacogenomics. 2024;25(12-13):503-513. https://doi.org/10.1080/14622416.2024.2406213
• van den Broek WWA, Ingraham BS, Pereira NL, Lee CR, Cavallari LH, et al. Genotype-guided antithrombotic therapy. J Am Coll Cardiol. 2024;84(12):1107-1118. https://doi.org/10.1016/j.jacc.2024.06.038
• Alhurayri F, Jaynes HA, Overholser BR, Sowinski KM, Kovacs RJ, Tisdale JE. Drug-induced increase in dispersion of ventricular repolarization in patients with heart failure with preserved ejection fraction. Int J Cardiol. 2025;418:132631. https://doi.org/10.1016/j.ijcard.2024.132631
• Huang CY, Overholser BR, Sowinski KM, Jaynes HA, Kovacs RJ, Tisdale JE. Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction. PLoS One. 2024;19(8):e0308999. https://doi.org/10.1371/journal.pone.0308999
• Huang CY, Overholser B, Sowinski KM, Jaynes HA, Kovacs J, Tisdale JE. Arrhythmias in patients with heart failure prescribed dofetilide or sotalol. JACC Adv. 2024;11:101354. https://doi.org/10.1016/j.jacadv.2024.101354
• Patil T, Gregory M, Savona N, Jarmukli N, Leonard CE. Evaluating the real-world safety of icosapent ethyl versus omega-3 polyunsaturated fatty acid in nationwide US veterans cohort: examining atrial fibrillation and bleeding endpoints. Clin Drug Investig. 2025;45(2):69-84. https://doi.org/10.1007/s40261-024-01417-4
• Joshi M, Pham C, Deng H, Mathew S, Norton RM, Kim K, Touchette DR, Tilton JJ. Cost-effectiveness of a pharmacist-led medication therapy management clinic for management of type 2 diabetes. J Am Pharm Assoc. 2025;65(1):102253. https://doi.org/10.1016/j.japh.2024.102253
• Kolpek JH, Haas CE, Kolesar JM, Tisdale JE. Diversity, equity, inclusion, and accessibility: alignment with the mission and core values of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2024;7:1240-1244. https://doi.org/10.1002/jac5.2052
• Hsia SL, Mackey G, Mondal R, Zhou C. Student perceptions and outcomes from asynchronous versus synchronous remote learning in a pharmacy skills course. Curr Pharm Teach Learn. 2025;17(5):102299. https://doi.org/10.1016/j.cptl.2025.102299
• Lee KC, Gruenberg K, Namba JM, Valle-Oseguera CS, Awdishu L, Assemi M, Corelli RL, Zhou C. Collaboration for competence: unlocking the win-win of shared OSCE resources. Am J Pharm Educ. 2025;89(2):101352. https://doi.org/10.1016/j.ajpe.2024.101352

New ACCP Fellows

• Caitlin Gibson
• Jessica Tilton

 Other Notable Achievements

• Arden Barry: Fellow of the Canadian Society of Healthcare-Systems Pharmacy (FCHSP).
• Jenna Cox: Fellow of the American College of Critical Care Medicine (FCCM).
• Robert DiDomenico: Appointed Associate Editor of the Journal of the American College of Clinical Pharmacy (JACCP).
• Monique Conway Godfrey: BCCP.
• Sara Anne Meyer: BCCP.
• Nathan Stockman: BCCP.

Central Nervous System PRN

Grants

• Joshua Caballero: Stressors and Coping Strategies in Rural Under-represented Workers in Georgia. Rural Engagement Workshop Academic Faculty Seed Grant. 2024. Principal Investigator ($6650).
• Joshua Caballero: A Digital Health App for Older Hispanic Adults with Type 2 Diabetes. NIH R21 Exploratory/Developmental Research Grant 2024. Principal Investigator ($550,515) (3 years).

 Publications

• Boylan PM, Santibañez M, Thomas J, Weeda E, Noel ZR, Caballero J. Cannabinoids for obstructive sleep apnea: a systematic review. Pharmacotherapy. 2024;44(11):880-891. https://doi.org/10.1002/phar.4622
• Cassara C, Xu J, Chen X, Hall D, Young HN, Caballero J. Use and discontinuation rates of long-acting injectable antipsychotics between race/ethnicity in older adults using Medicaid databases. J Am Geriatr Soc. 2025 Feb 5. [Epub ahead of print] https://doi.org/10.1111/jgs.19386
• Davis R, Xu J, Chen X, Hall D, Moretz MM, Young HN, Caballero J. Appropriate use of single dose injectable aripiprazole lauroxil in the treatment of schizophrenia. Ment Health Clin. 2024;14(6):334-338. https://doi.org/10.9740/mhc.2024.12.334
• Rawal S, Welsh JW, Yarbrough CR, Abraham AJ, Crawford ND, Khail JW, Chinchilla A, Caballero J, et al. Community pharmacy-based buprenorphine programs and pharmacists roles, knowledge, attitudes, and barriers to providing buprenorphine-related services: a systematic review. J Am Pharm Assoc (2003). 2024 Dec 27. [Epub ahead of print] https://doi.org/10.1016/j.japh.2024.102319
• Rawal S, Xu J, Chen X, Hall D, Ricabal L, Young HN, Caballero J. Assessing the utilization of current procedural terminology codes in pharmacists’ services using MarketScan data. Am J Health Syst Pharm. 2024 Oct 18. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae314
• Laswell E, Peters D, Orchard J. The pharmacologic management of status epilepticus in pregnant patients: a scoping review. J Pharm Pract Res. 2024;54:353-367. https://doi.org/10.1002/jppr.1934
• Ercis M, Cole KC, Dierkhising RA, Ozerdem A, Markota M, Singh B, McElroy SL, Frye MA, Leung JG. Clinical and demographic predictors of early clozapine discontinuation across mood and psychotic disorders. J Clin Psychopharmacol. 2025;45(2):85-91. https://doi.org/10.1097/JCP.0000000000001951
• Silvia RJ, Mohammad I, English C, Bradley BA, Ottney A, Crismon ML. A call to action for ambulatory care pharmacists for the treatment of depression and anxiety in primary care: an opinion paper of the Ambulatory Care and Central Nervous System Practice and Research Networks of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2025 Feb 17. [Epub ahead of print] https://doi.org/10.1002/jac5.70009

 Other

• Richard Silvia: Fellow, American Association of Psychiatric Pharmacists (FAAPP).

Clinical Administration PRN

Publications

• Hyland SJ, Fada M, Secic M, Fada R, Lockwood MM, Parrish RH 2nd. Risk-stratified venous thromboembolism chemoprophylaxis after total joint arthroplasty: evaluation of an institutional approach. J Clin Med. 2025;14(2):366. https://doi.org/10.3390/jcm14020366
• Sohn C, Roberts J, Jean-Jacques E, Parrish RH 2nd. A causal model for predicting the impact of pharmacotherapy on colorectal surgery outcomes. World J Surg. 2024;48(12):2831-2842. https://doi.org/10.1002/wjs.12387

Other Notable Achievements

• Richard H. Parrish:
  • Medicaid provider, Commonwealth of Pennsylvania.
  • Perioperative Care PRN award has been named the “Richard H. Parrish II Lifetime Achievement Award” to recognize a career-long contribution to perioperative care and the PRN.

Community-Based PRN

The Community-Based PRN is looking forward to another great year of working with ACCP to uplift the value of clinical community pharmacy and improve patient care across the health care continuum.

Awards

• Rebecca Lahrman: University of Cincinnati’s Graduate of the Last Decade (GOLD).

Publications

• Eddy E, Ballou J, Finke J, Nuffer W, Avena-Woods C, Bandy V, Doucette W, Guthrie K, McDonough R, Snyder M, Varin J. Medication therapy management: the evolution of clinical pharmacy services in U.S. community-based pharmacy practice—an opinion of the Community-Based Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2024;7(12):1228-1234. https://doi.org/10.1002/jac5.2047
• Harris IM, Hilaire ML, Jeon M, et al. Commentary: pharmacists’ role in combatting the medical misinformation epidemic. J Am Coll Clin Pharm. 2024;7(9):947-951. https://doi.org/10.1002/jac5.2005
• Jones E, Mohammad I (as part of the Advancing Pharmacist Payment Parity Workgroup). State of the union: a review of state-based laws and regulations supporting pharmacist payment for clinical services. J Am Coll Clin Pharm. 2024;7(9):908-925. https://doi.org/10.1002/jac5.2008
• Chan A, Baker WL, Abazia D, Bauman J, DeVane CL, Goodlet KJ, Hall N, Hicks JK, Jones E, et al. Impact of artificial intelligence on future clinical pharmacy research and scholarship. J Am Coll Clin Pharm. 2025 Feb 13. [Epub ahead of print] https://doi.org/10.1002/jac5.70003
• Lahrman R. Bringing providers into the community pharmacy: experiential education. J Am Pharm Assoc (2003). 2025;65(1):102276. https://doi.org/10.1016/j.japh.2024.102276

Presentations

• Michelle Jeon:
  • Jeon M. No cap: continuing the fight against medical misinformation. Presented at: APhA Day of NP Life; October 2024; Washington, DC.
  • Garcia B, Lakshminarayanan S, Jeon M. Beyond the counter: integrating pharmacy students in a community pharmacy HIV testing pilot program. Poster presented at: 2024 ACCP Annual Meeting; October 12-15, 2024; Phoenix, AZ.
  • Zupec J, Jeon M, Thomson M. Changes in course delivery and active learning methods on P1 student exam performance. Poster presented at: 2024 ACCP Annual Meeting; October 12-15, 2024; Phoenix, AZ.
• Ellen Jones:
  • Jones E. The beat goes on: updates in atrial fibrillation guidelines. Presented at: 2024 ACCP Annual Meeting; October 12-15, 2024; Phoenix, AZ; and ASHP 2024 Midyear Meeting; December 7-12; New Orleans, LA.
  • Freas M, Socco S, Hanavan K, Jones E, Paul S. Pharmacist-led implementation of pharmacogenomic services for behavioral health in outpatient, collaborative settings. Poster presented at: 2024 ACCP Annual Meeting; October 13, 2024; Phoenix, AZ.
• Pinky F, Fava J, Rukat C, Barnes BJ. Outpatient prescribing patterns in the treatment of insomnia, depression, and anxiety by prescriber type, specialty, and patient age group. Abstract accepted 22 January 2025 for poster presentation at: 2025 APhA Annual Meeting and Exposition; March 21-24, 2025; Nashville, TN.

Other Notable Achievements

• Joeseph Fava: Navigating pharmacy care from prescription to patient. Expert panelist at: Annual Wellness & Epilepsy Conference; Epilepsy Foundation of Michigan; November 2, 2024; Livonia, MI.

Critical Care PRN

Promotions

• Eden Brewington: Neurocritical Care Pharmacist, UK HealthCare.
• Austin Camp: Associate Professor of Pharmacy Practice, Union University.
• Michael Kenes: Clinical Associate Professor, College of Pharmacy, University of Michigan.
• Rachel Lucas: Director of The Rural and Underserved Service Track (TRUST).
• Zach Smith: Series Editor: Critical Care Self-Assessment Program for the American College of Clinical Pharmacy.

 Awards

• Sarah Blackwell: Tenet Hero, Tenet Healthcare.
• Paige Bradshaw: Star Research Award, Society of Critical Care Medicine.
• Jenna Cox: Clinical Practice Award, American College of Pharmacy Cardiology PRN.
• Brian Gilbert: 40 Under 40 Honoree, University of Florida.
• Leslie Hamilton:
  • Presidential Citation, Neurocritical Care Society.
  • Mentor of the Year Award, American College of Clinical Pharmacy Critical Care PRN.
  • Best Poster Runner-Up, American College of Clinical Pharmacy Education and Training PRN.
• Judi Jacobi: Paul F. Parker Medal, American College of Clinical Pharmacy.
• Rachel Lucas: Residency Preceptor of the Year, Guthrie Robert Packer Hospital.

 Grants

• Mojdeh Heavner (Principal Investigator), Kelli Keats, XianYan Chen, Susan Smith, Andrea Sikora, Maureen Seckel, Greg Martin. Optimizing Pharmacist Team-Integration for ICU Patient Management (OPTIM). American Society of Health-System Pharmacists Optimizing Technology Solutions Innovation Grant ($29,999).
• Kelli Keats (Principal Investigator), Andrea Sikora. Optimizing Pharmacist Team-Integration for ICU Patient Management (OPTIM): Essential Database Construction for Exploration of the Optimal Pharmacist-to-Patient Ratio. American College of Clinical Pharmacy Critical Care PRN Member Research Grant ($5000).

 Publications

• Bolesta S, Wellings F, Sklanka K, Rahman A, Ciucci A, Trombetta DP. Caution work zone: building a faculty and staff mentoring program. Am J Pharm Educ. 2024;88(9):101138. https://doi.org/10.1016/j.ajpe.2024.101138
• McFarland MS, Buck M, Jacobi J. The outcomes of implementing and integrating comprehensive medication management in team-based care: a review of the evidence on quality, access and costs, December 2024. GTMRx. https://gtmr.org/wp-content/uploads/2024/12/GTMR-evidence-doc-2024-FINAL.pdf
• El Ouweini AE, Don J, Alzuabi H, Levien T, Malaeb D. Assessment of vancomycin utilization in intensive care unit patients of a tertiary care hospital in the United Arab Emirates. Pharm Pract. 2024;22(4):1-7. https://doi.org/10.18549/PharmPract.2024.4.2977
• El Ouweini AE, Malaeb D, Levien T, Slevaraju K, Loaitan VO. Assessment of proton pump inhibitors utilization in intensive care units patients of a tertiary care hospital in the United Arab Emirates. Pharm Pract. 2024;20(3). https://doi.org/10.18549/PharmPract.2024.3.2978
• Barakat M, Malaeb D, El Ouweini A, et al. Healthcare providers’ perspectives on corticosteroid-containing drugs: a cross-sectional study in the United Arab Emirates. Futur J Pharm Sci. 2024;10:114. https://doi.org/10.1186/s43094-024-00690-6
• Erstad BL, Jacobi J, Kehoe WA, Nebit S, Seaton T. Serving as a professional association board member: benefits to leaders and their employers. J Am Coll Clin Pharm. 2024;7:1068-1070. https://doi.org/10.1002/jac5.2026
• Gilbert BW, Bissell Turpin BD. The evolution of evidence-based medicine. Am J Health Syst Pharm. 2024 Sept 4. [Epub ahead of print] https://doi:10.1093/ajhp/zxae253
• Aljadeed R, Gilbert BW, Karaze T, Rech MA. Intravenous push administration of anti-seizure medications. Front Neurol. 2025;15:1503025. https://doi:10.3389/fneur.2024.1503025
• Townsend BR, Malka ST, Di Paola SG, Nisly AE, Gilbert BW. DRopEridol for abdominal pain in the emergency department for morphine equivalent reduction. The DREAMER study. Am J Emerg Med. 2025 Jan 4. [Epub ahead of print] https://doi:10.1016/j.ajem.2024.12.082
• Townsend B, Slechta J, Gilbert BW. Prothrombin complex concentrate administration timing in warfarin-associated intracranial hemorrhage. Am J Emerg Med. 2024;76:136-139. https://doi:10.1016/j.ajem.2023.11.040
• Groth CM, Droege CA, Sarangarm P, Cucci MD, Gustafson KA, Connor KA, Kaukeinen K, Acquisto NM, Chui SHJ, Dixit D, Flannery AH, Glass NE, Horng H, Heavner MS, Kinney J, Peppard WJ, Sikora A, Erstad BL. Multicenter retrospective review of ketamine use in pediatric intensive care units (Ketamine-PICU study). Crit Care Res Pract. 2024 Jul 27. [Epub ahead of print] https://doi.org/10.1155/2024/6626899
• Hamilton LA, Wofford BR, Havrda DE, Hall EA, Schoelles JL, Shelton CM, Rowe AS, Crill CM, Swanson JM. Predictors of success in obtaining postgraduate residency or fellowship. Am J Pharm Educ. 2024;88(10):101271. https://doi:10.1016/j.ajpe.2024.101271
• Chastain DB, Tu PJ, Brizzi M, Keedy CA, Baker AN, Jackson BT, Ladak AF, Hamilton LA, et al. Managing modern antiretroviral therapy in the intensive care unit: overcoming challenges for critically ill people with human immunodeficiency virus. Open Forum Infect Dis. 2024;11(5):ofae213. https://doi:10.1093/ofid/ofae213
• He J, Cox TR, Gilbert BW. Phytonadione utilization and the risk of bleeding in chronic liver disease. Hosp Pharm. 2024;59(6):660-665. https://doi:10.1177/00185787241269114
• Heavner MS. Next generation of critical care pharmacist practice studies: beyond essential. Am J Health Syst Pharm. 2024;81(18):884-889. https://doi.org/10.1093/ajhp/zxae146
• Henry K, Deng S, Chen X, Zhang T, Devlin J, Murphy D, Smith S, Murray B, Kamaleswaran R, Most A, Sikora S. Unsupervised machine learning analysis to identify patterns of ICU medication use for fluid overload prediction. Pharmacotherapy. 2025;00:1-11. https://doi.org/10.1002/phar.4642
• Hyland SJ, Eaton RE, Max ME, Egbert SB, Wong SA, Blais DM. Pharmacotherapy of acute ST-elevation myocardial infarction and the pharmacist’s role, part 1: patient presentation through revascularization. Am J Health Syst Pharm. 2024 Oct 25. [Epub ahead of print] https://doi:10.1093/ajhp/zxae303
• Hyland SJ, Max ME, Eaton RE, Wong SA, Egbert SB, Blais DM. Pharmacotherapy of acute ST-elevation myocardial infarction and the pharmacist’s role, part 2: complications, postrevascularization care, and quality improvement. Am J Health Syst Pharm. 2024 Oct 25. [Epub ahead of print] https://doi:10.1093/ajhp/zxae310
• Jacobi J. Thinking about my heroes: the 2024 Paul F. Parker medal for a lifetime of service to pharmacy. J Am Coll Clin Pharm. 2024;7:1144-1145. https://doi.org/10.1002/jac5.2053
• Barker AK, Valley TS, Kenes MT, Sjoding MW. Early deep sedation practices worsened during the pandemic among adults patients without COVID-19: a retrospective cohort study. Chest. 2024;166(1):118-126. https://doi:10.1016/j.chest.2024.01.019
• Ingebrigtson M, Schang S, Hyzy RC, McSparron JI, Chen X, Tapper EB, Kenes MT. Phenobarbital versus benzodiazepines for alcohol withdrawal in the medical intensive care unit (ICU): a retrospective cohort study. J Pharm Pract. 2024;38(2):231-236. https://doi.org/10.1177/08971900241273144
• Klosko R, Schwier N. Acute coronary syndromes. In: NAPLEX Review Guide. 5th ed. McGraw Hill Medical; 2024.
• Klosko RC, Whitson B, Lampert B, McLaughlin E, Orzel L. Safety of enoxaparin in patients implanted with continuous flow left ventricular assist devices. Artif Organs. 2024 Nov 27. [Epub ahead of print] https://doi.org/10.1111/aor.14908
• Linn DD, Renew JR. Neuromuscular monitoring: a tutorial for pharmacists. Am J Health Syst Pharm. 2025;82(5):e242-e251. https://doi:10.1093/ajhp/zxae287
• Isaacs AN, Linn DD, Saum LM, Miller ML, Richardson E, Li Y, Beckett RD. Prospective evaluation of a residency preparation checklist for PGY1 match success. Am J Health Syst Pharm. 2024 Dec 9. [Epub ahead of print] https://doi:10.1093/ajhp/zxae354
• Murray DS, Gilbert BW, Cox TR. Pilot study on the impact of early subcutaneous basal insulin administration in diabetic ketoacidosis. J Intensive Care Med. 2024;39(10):980-984. https://doi:10.1177/08850666241247516
• Nelson NR, Farina N, Rhoney DH. Utilisation of a national database to characterise renal function in patients with COVID19 infection. Clin Transl Disc. 2025;5:e70027. https://doi.org/10.1002/ctd2.70027
• Nelson NR, Quinn NJ, Bills S, Dellabella A, Gregar SE, Lear A, Marsolek L, Mounce C, Tobin M. Scoping review of drug dosing recommendations in sustained low-efficiency dialysis. Pharmacotherapy. 2024;44(12):948-955. https://doi.org/10.1002/phar.4628
• Jeghers MA, Ji C, Newman K, Leung N, Roberts RJ. Evaluation of pharmacist involvement in emergency response. J Pharm Pract. 2024 Dec 22. [Epub ahead of print] https://doi:10.1177/08971900241310308
• Smith ZR, Palm NM, Smith SE, Dixit D, Keats K, Ciapala SR, Tran T, Newsome AS, Heavner MS. Critical care pharmacist perspectives on optimal practice models and prioritization of professional activities: a cross-sectional survey. Am J Health Syst Pharm. 2024;81(24):1267-1277. https://doi.org/10.1093/ajhp/zxae151
• Liske J, Patel N, Makowski C, Awdish R, Smith ZR. Risk evaluation and mitigation strategy compliance for pulmonary hypertension medications after policy implementation with computerized provider order entry support. Am J Health Syst Pharm. 2024;82(1):23-31. https://doi.org/10.1093/ajhp/zxae228
• Houston AJ, Wilson CS Jr, Gilbert BW. Antiseizure medication practices in the adult traumatic brain injury patient population. Am J Emerg Med. 2024;86:125-128. https://doi:10.1016/j.ajem.2024.10.009
• Zavala S, Choudhry S, Elfessi Z. Intentional ivabradine overdose: a case report. Vis J Emerg Med. 2024;37:102117. https://10.1016/j.visj.2024.102117
• Elfessi Z, Portnoy E, Karydes H, Zavala S. Fournier’s gangrene and sodium-glucose cotransporter 2 inhibitor use: a report of two cases. J Pharm Pract. 2024 Nov 20. [Epub ahead of print] https://doi:10.1177/08971900241302881

 New ACCP Fellows

• Christopher Adams
• Jeffrey Barletta
• Deepali Dixit
• David Hill
• Young Lee

 Other Notable Achievements

• Scott Bolesta: Secretary, Pennsylvania Society of Health-System Pharmacists.
• Eden Brewington: Chair, ACCP Critical Care PRN Trainee Engagement Committee.
• Jenna Cox: President-Elect, Carolinas/Virginias SCCM.
• Ahmad El Ouweini:
  • Chair, IVPN-Network Webinars Organizing Committee.
  • Leader, IVPN-Critical Care Listserv.
  • Completed 2-year Post-Doctoral Fellowship in Clinical Pharmacy Research with a focus on Critical Care, Gulf Medical University in joint collaboration with Washington State University.
• Leslie Hamilton:
  • Chair, ACCP FCCP Credentials Committee.
  • Co-Chair, Neurocritical Care Society Annual Meeting.
  • Co-Lead, SCCM CPP Programming Committee Charge.
  • Senior Editor, SCCP CPP Pharmacy Literature Update.
  • Chair, Tennessee Pharmacists Association Awards Committee.
• Joanna He:
  • BCCCP.
  • Junior Charge Lead, SCCM CPP Patient Safety Committee.
• Kelli Henry: Patient Safety Update Senior Charge Lead, SCCM CPP Patient Safety Committee.
• Judi Jacobi: President, Midwest Chapter of SCCM.
• Michael Kenes: BPS Critical Care Specialty Council.
• Megan Lail: Residency Program Director, PGY2 Critical Care at McLeod Regional Medical Center.
• Rachel Lucas:
  • President, New York State Chapter of the American College of Clinical Pharmacy.
  • President, Southern Tier Society of Health-System Pharmacists.
• Liz Padgett: BCCCP.
• Russel Roberts: Residency Program Director, PGY2 Emergency Medicine at Massachusetts General Hospital.
• Zach Smith: President, SCCM Michigan Chapter.
• May Zhang: BCCCP.

Drug Information PRN

Publications

• Dylewski A, Holder AC, Brown JN. Use of cholinesterase inhibitors for treatment and prevention of cognitive adverse effects of electroconvulsive therapy: a systemic review. J ECT. 2024 Dec 17. [Epub ahead of print] https://doi.org/10.1097/YCT.0000000000001095
• Shultz B, Mucksavage J, Goliak K, Phillips J, Thambi M. Investigating the perceptions and behaviors that contribute to student preparation for the NAPLEX exam. Curr Pharm Teach Learn. 2025;17(2):102228. https://doi.org/10.1016/j.cptl.2024.102228
• Chen AMH, Thornby KA, Law AV. Curricular assessment blueprint and needs analysis for the social, administrative, and behavioral foundational sciences. Am J Pharm Educ. 2025;89(1):101346. https://doi.org/10.1016/j.ajpe.2024.101346
• Stallworth S, Ricco M, Thornby K, Leonhard A, Schadler A, Cain J. A survey analysis of motivations and perceived consequences of work hours among pharmacy students. Am J Pharm Educ. 2024;88(12):101318. https://doi.org/10.1016/j.ajpe.2024.101318

Presentations

• Steven Johnson: Innovative formulary management strategies for a more complex word: innovations in drug information practice and research 2024. Presented at: ASHP Midyear Clinical Meeting; December 11, 2024; New Orleans, LA.
• Steven Johnson and Julie Sibbesen: Teaching learners to identify and reduce the spread of medical misinformation. Presented at: ACCP Annual Meeting; October 15, 2024; Phoenix, AZ.
• Faria Munir: Bridging the healthcare gap for the homeless through technology implementation. Presented at: Consortium of Universities for Global Health; February 28, 2025; Atlanta, GA.

Other Notable Achievements

• Faria Munir: Interviewed for “Telehealth kiosks connect underserved to local resources.” OSF Healthcare. 2024. https://newsroom.osfhealthcare.org/telehealth-kiosks-connect-underserved-to-local-resources/
• Julie Sibbesen: Interviewed for “Combatting medical misinformation: strategies for patient education, curriculum integration, and social media management.” Pharmacy Times. 2024. https://www.pharmacytimes.com/view/combatting-medical-misinformation-strategies-for-patient-education-curriculum-integration-and-social-media-engagement

Education and Training PRN

Promotions

• Linda Sobeski: Associate Dean for Kearney Campus at University of Nebraska College of Pharmacy.

Awards

• Abigail Elmes-Patel: Best Poster, Education and Training Practice and Research Network: Jarrett JB, Elmes AT, Allen S, Djuric Kachlic M, Schriever A, Driscoll T, Tekian A, Cheung J, Podsiadlik E, Haines ST, Schwartz A. Longitudinal self-assessment of students in pharmacy experiential education using entrustable professional activities. Presented at: 2024 ACCP Annual Meeting; October 2024; Phoenix, AZ.

Grants

• Joshua Caballero:
  • Stressors and Coping Strategies in Rural Under-represented Workers in Georgia. Rural Engagement Workshop Academic Faculty Seed Grant. 2024. Principal Investigator ($6550).
  • A Digital Health App for Older Hispanic Adults with Type 2 Diabetes. NIH R21 Exploratory/Developmental Research Grant 2024. Principal Investigator ($550,515) (3 years).

Publications

• Denny O, Albanese NP, Siwarski N, Meaney C, Monte SV. Efficacy and safety of sodium-glucose cotransporter-2 inhibitor continuation in patients with type 2 diabetes and late-stage chronic kidney disease. J Pharm Technol. 2024 Dec 19. [Epub ahead of print] https://doi.org/10.1177/87551225241302731
• Pizzutelli N, Maerten-Rivera J, Albanese N, et al. Assessment of student well-being and identification of associated factors. Curr Pharm Teach Learn. 2025;17:102298. https://doi.org/10.1016/j.cptl.2025.102298
• Baalmann A, Sherrill C, Aguiniga A, Wesling M, Jones E, De Bittner MR, Westberg S, Challen L, Lingow S, Wheeler S (as part of the Advancing Pharmacist Payment Parity Workgroup). State of the union: a review of state-based laws and regulations supporting pharmacist payment for clinical services. J Am Coll Clin Pharm. 2024;7(9):908-925. https://doi.org/10.1002/jac5.2008
• Litten K, Folz H, Lobkovich A, Sherrill CH, Berlie H. Integrating continuous glucose monitoring into doctor of pharmacy curricula. J Am Coll Clin Pharm. 2025;8:129-135. https://doi.org/10.1002/jac5.2076
• Boylan PM, Santibañez M, Thomas J, Weeda E, Noel ZR, Caballero J. Cannabinoids for obstructive sleep apnea: a systematic review. Pharmacotherapy. 2024;44(11):880-891. https://doi.org/10.1002/phar.4622
• Foote DC, Miller JL, Skrepnek GH, Neely S, Bennett K, Boylan PM. Montelukast deprescribing in outpatient specialty clinics: a single center cross-sectional study. Explor Res Clin Soc Pharm. 2024;16:100509. https://doi.org/10.1016/j.rcsop.2024.100509
• Santibañez M, Boylan PM, Paloucek F, Caballero J. The social media “expert” phenomenon: need for increased pharmacy practice transparency. Front Commun (Lausanne). 2024;9:1467468. https://doi.org/10.3389/fcomm.2024.1467468
• Young J, Spisany T, Guidry C, Hong J, Le J, El Rassi E, Boylan P. Dupilumab for chronic obstructive pulmonary disease: a systematic review. Biologics (Basel). 2025;5(1):5. https://doi.org/10.3390/biologics5010005
• Cassara C, Xu J, Chen X, Hall D, Young HN, Caballero J. Use and discontinuation rates of long-acting injectable antipsychotics between race/ethnicity in older adults. J Am Geriatr Soc. 2025 Feb 5. https://doi.org/10.1111/jgs.19386
• Davis R, Xu J, Chen X, Hall D, Moretz MM, Young HN, Caballero J. Appropriate use of single-dose injectable aripiprazole lauroxil in the treatment of schizophrenia. Ment Health Clin. 2024;14(6):334-338. https://doi.org/10.9740/mhc.2024.12.334
• Rawal S, Welsh JW, Yarbrough CR, Abraham AJ, Crawford ND, Khail JW, Chinchilla A, Caballero J, et al. Community pharmacy-based buprenorphine programs and pharmacists roles, knowledge, attitudes, and barriers to providing buprenorphine-related services: a systematic review. J Am Pharm Assoc (2003). 2024 Dec 27. [Epub ahead of print] https://doi.org/10.1016/j.japh.2024.102319
• Rawal S, Xu J, Chen X, Hall D, Ricabal L, Young HN, Caballero J. Assessing the utilization of current procedural terminology codes in pharmacists’ services using MarketScan® data. Am J Health Syst Pharm. 2024 Oct 18. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae314
• Burchette J, Covert K, Tu P, White BP, Chastain DB, Cluck D. Pivmecillinam for uncomplicated acute cystitis: a contemporary review. Ann Pharmacother. 2024 Dec 7. [Epub ahead of print] https://doi.org/10.1177/10600280241288554
• Lanier C, Brumit J, Tharp J, Crawford J, White K, Wilson V, Covert K. Incidence and potential predictors of SGLT2 inhibitor initiation in acute hospitalized patients with heart failure. Am J Health Syst Pharm. 2025 Feb 6. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxaf025
• Lanier C, Covert K, Melton T. Cefepime-enmetazobactam: a drug review of a novel beta-lactam/beta-lactamase inhibitor. Ann Pharmacother. 2024 Sep 27. [Epub ahead of print] https://doi.org/10.1177/10600280241279904
• Elmes-Patel AT, Allen SA, Djuric Kachlic M, et al. Preceptor perspectives on entrustable professional activity-based assessment in advanced pharmacy practice experiences. Am J Pharm Educ. 2024;88(12):101332. https://doi.org/10.1016/j.ajpe.2024.101332
• Taylor DR, Schwartz A, Elmes-Patel AT, Marty AP, Hennus MP. Monitoring and evaluating EPAs and EPA frameworks. In: ten Cate O, Burch VC, Chen C, Chou FC, Hennus MP, eds. Entrustable Professional Activities and Entrustment Decision-Making in Health Professions Education. Ubiquity Press; 2024. https://www.ubiquitypress.com/site/chapters/e/10.5334/bdc.k/
• Gibson CM, Beard MM, Escano AK, et al. Metolazone vs chlorothiazide in acute heart failure patients with diuretic resistance and renal dysfunction: a retrospective cohort study. J Cardiovasc Pharmacol. 2024;84(4):451-456. https://doi.org/10.1097/FJC.0000000000001623
• Gibson CM, Howard ML, Haight RC. Validation of an instrument to assess student pharmacist self-authorship. Curr Phar Teach Learn. 2025;17(2):102264. https://doi.org/10.1016/j.cptl.2024.102264
• Gibson CM, Lacroix M, Hevener KE. Professional pharmacy fraternities as a mechanism for co-curricular learning: a qualitative analysis of two organizations. Am J Pharm Educ. 2024;88:101249. https://doi.org/10.1016/j.ajpe.2024.101249
• Ahmed AF, Zachariah S, Ismail AH, Gibson CM. Variation among venous thromboembolism risk assessment tools for post-cesarean patients: a retrospective cohort study. Blood Coagul Fibrinolysis. 2024;35(8):357-361. https://doi.org/10.1097/MBC.0000000000001325
• Clements JN, McClendon K, Borchert J, Ciapala SRL, Courtney LA, Cummings J, Fallon JM, Fritz MK, Gibson CM, Isaacs AN, et al. ACCP guideline: teaching experiences in pharmacy residency. J Am Coll Clin Pharm. 2025;8:62-69. https://doi.org/10.1002/jac5.2066
• Fox J, Bond R, Matulewicz A, Gibson CM, Sanders K, Dixon DL. Exploring the impact of generation status on pharmacy admissions: a comparative study of first-generation and continuing-generation college students. Am J Pharm Educ. 2024;88:101258. https://doi.org/10.1016/j.ajpe.2024.101258
• Chan A, Baker WL, Abazia D, Bauman J, DeVane CL, Goodlet KJ, Hall N, Hicks JK, Jones E, et al. Impact of artificial intelligence on future clinical pharmacy research and scholarship. J Am Coll Clin Pharm. 2025 Feb 13. [Epub ahead of print] https://doi.org/10.1002/jac5.70003
• Khorassani F, Entsuah-Boateng N, Sayer M, Ozaki A. Racial disparities in mood stabilizer prescribing in mania in nonpsychotic, hospitalized patients with bipolar I disorder. J Clin Psychiatry. 2025;86(1):24m15524. https://doi.org/10.4088/JCP.24m15524
• Ensign D, Nisly SA, Pardo C. The future of generative AI in continuing professional development (CPD): crowdsourcing the alliance community. J CME. 2024;13(1):2437288. https://doi.org/10.1080/28338073.2024.2437288
• O’Connell MB, DeLellis TM. Musculoskeletal and connective tissue disorders. In: Hutchinson LC, Sleeper R, eds. Fundamentals in Geriatric Pharmacotherapy. 3rd ed. American Society of Health-System Pharmacists. In press.
• Marcath M, Craig K, O’Connell MB. Impact of reproductive health education seminars on college students’ contraception and safe sex knowledge and behaviors. Pharmacy. 2025;13(2):39. https://doi.org/10.3390/pharmacy13020039
• Peddi AN, Caldas LM, Sisson EM, Yousufzai S, Frankart LM. Development and assessment of an online, asynchronous state-specific pharmacy law continuing education program for multistate pharmacy jurisprudence examination preparation. Innov Pharm. 2025;15(4). https://doi.org/10.24926/iip.v15i4.6128
• Crawford AN, Anksorus HN, Clark Dula CA, Fredrickson ME, Peddi AN, et al. Counting on change: conquering challenges in teaching pharmaceutical calculations. Am J Pharm Educ. 2024;88(9):101259. https://doi.org/10.1016/j.ajpe.2024.101259
• Evoy KE, Balli M, Carris NW, Castelli G, Isch JL, Meredith AH, Mohammad I, Philbrick A, Prasad-Reddy L, Riccio KKC, Schumacher C, Soric MM, eds. ACCP Ambulatory Care Pharmacist’s Survival Guide. 5th ed. American College of Clinical Pharmacy; 2024.
• Steuber TD, Trujillo D, Kleppinger EL, Andrus MR, Pinner NA, Hornsby L, et al. Impact of curricular content reduction on student reported mental and physical health. Am J Pharm Educ. 2025 Feb 6. [Epub ahead of print] https://doi.org/10.1016/j.ajpe.2025.101367
• Chen AMH, Thornby KA, Law AV. Curricular assessment blueprint and needs analysis for the social, administrative, and behavioral foundational sciences. Am J Pharm Educ. 2025;89(1):101346. https://doi.org/10.1016/j.ajpe.2024.101346
• Stallworth S, Ricco M, Thornby K, Leonhard A, Schadler A, Cain J. A survey analysis of motivations and perceived consequences of work hours among pharmacy students. Am J Pharm Educ. 2024;88(12):101318. https://doi.org/10.1016/j.ajpe.2024.101318
• Miranda AC, Cornelio CK, Tran BAC, Fernandez J. Sotatercept: a first-in-class activin signaling inhibitor for pulmonary arterial hypertension. J Pharm Tech. 2025 Feb 22. [Epub ahead of print] https://doi.org/10.1177/87551225251317957

Presentations

• Nicole Albanese:
  • Exploring medication options for adult and adolescent obesity. Presented at: ASHP 2024 Midyear Clinical Meeting and Exhibition; December 11, 2024; New Orleans, LA.
  • Complementary medicine in 2024 and conversations about vitamins with patients. Presentation title: Vitamania: is more actually better? Evaluating the efficacy and safety of vitamins in disease state management. Presented at: 2024 ACCP Annual Meeting; October 2024; Phoenix, AZ.
  • Navigating optimal medication strategies and deprescribing in the landscape of intensive therapeutic lifestyle changes for persons with type 2 diabetes. Presentation title: Precision care: deprescribing antihyperglycemics in the setting of intensive, therapeutic lifestyle interventions in type 2 diabetes. Presented at: 2024 ACCP Annual Meeting; October 2024; Phoenix, AZ.
• Berlie H, Litten K, Folz H, Lobkovich A, Sherrill CH. Multi-institutional approaches to incorporating continuous glucose monitoring (CGM) into pharmacy education. Collaborative AACP webinar presented with the Technology in Pharmacy Education & Practice SIG and the Curriculum SIG; February 2025; virtual.
• Boylan PM. Theophylline, anti-leukotrienes for the treatment of airway allergic diseases. Presented at: Henry Stewart Talks; February 2025; virtual.
• Covert K. Gastrointestinal: is it time to say goodbye to the PPI. 2024 ACCP Annual Meeting; October 2024; Phoenix, AZ.
• Abigail Elmes-Patel:
  • Elmes A: “Practical solutions for EPAs in competency-based assessment: identifying and addressing challenges with EPA implementation in experiential education” in “ACCP EDTR PRN Focus Session: Do You Trust Me? Entrustable Professional Activities as a Means to Facilitating and Assessing Practice Readiness.” Presented at: American College of Clinical Pharmacy Annual Meeting; October 2024; Phoenix, AZ.
  • Beeler S, Messmer S, Elmes AT, Jarrett JB, Mayer S, Murphy A, Jimenez AD. Evaluation of a mobile treatment unit: implementation of low-threshold buprenorphine in street-based programming. Presented at: Addiction Health Services Research 2024 Conference; October 2024; San Francisco, CA.
  • Coffee AN, Stranges P, Keller E, Infante A, Elmes-Patel AT. Patient factors associated with buprenorphine versus methadone use on a pharmacist-integrated inpatient opioid use disorder medication-assisted recovery consult service. Presented at: American Society of Health-System Pharmacists Annual Midyear Meeting; December 2024; New Orleans, LA.
  • Davis Z, Jarrett JB, Murphy A, Jimenez AD, Mayer S, Elmes AT, Messmer S. Traveling to the bus: a retrospective study of distance traveled to reach a mobile buprenorphine unit. Presented at: Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA) Annual Conference; November 2024; Chicago, IL.
  • Davis Z, Messmer S, Jarrett JB, Murphy A, Jimenez AD, Mayer S, Elmes AT. The road to recovery: utilization of a mobile outreach unit for medications for opioid use disorder. Presented at: Addiction Health Services Research 2024 Conference; October 2024; San Francisco, CA.
  • Infante A, Elmes AT. On the road to recovery: bringing ambulatory opioid use disorder (OUD) care into the community. Presented at: American Society of Health-System Pharmacists Annual Midyear Meeting; December 2024; New Orleans, LA.
• Jones E. The beat goes on: updates in atrial fibrillation guidelines. Presented at: ACCP Annual Meeting; October 2024; Phoenix, AZ; and ASHP Midyear Meeting; December 2024; New Orleans, LA.
• Steuber TD. Practice what you teach: innovating teaching methods—unique methods for teaching critical literature evaluation skills. American College of Clinical Pharmacy Annual Meeting; October 2024; Phoenix, AZ.

New ACCP Fellows

• Nicole P. Albanese
• Caitlin M. Gibson
• Taylor Steuber

Other Notable Achievements

• Kelly Covert: Named PGY2 Internal Medicine Residency Program Director.
• Andy Stone: Transitioning into the PGY1 Pharmacy/PGY2 Pharmacotherapy Residency Program Director role at The Ohio State University Wexner Medical Center.

Emergency Medicine PRN

Promotions

• Caitlin Brown: Associate Professor of Emergency Medicine, Mayo Clinic, Rochester, MN.
• Jennifer Lee: Critical Care & Emergency Medicine Clinical Pharmacy Manager, Inova Fairfax Medical Campus, Falls Church, VA.

Awards

• Nicole Acquisto: Living Legend Award, Pharmacy to Dose: The Critical Care Podcast.
• Deborah Booth: Pharmacist of the Year, New Jersey Society of Health-System Pharmacy; Behind the Scenes Award, New Jersey Emergency Nurses Association.
• Brian Gilbert: 2025 University of Florida 40 Under 40 Honoree, University of Florida Alumni Association.
• Megan Rech:
  • 2024 Top Editor Award Emergency Medicine Reviews and Perspectives (EM:RAP) CorePendium.
  • 2024 Editor’s Choice Award, Journal of the American College of Clinical Pharmacy.
  • 2024 Outstanding Reviewer, Journal of the American College of Clinical Pharmacy.

Publications

• Dash S, Acquisto NM, McElliott J, et al. Effect of a best practice advisory activated “kit in hand” naloxone distribution program in the emergency department. Am J Emerg Med. 2025;88:134-139. https://doi.org/10.1016/j.ajem.2024.11.065
• Forehand CC, Roberts RJ, Acquisto NM, et al. EXaminaTion of cRitical cAre PHArmacist pRoductivity MetricS (EXTRA-PHARMS): the clinical pharmacist’s perspective. J Am Coll Clin Pharm. 2024;7(11):1084-1093. https://doi.org/10.1002/jac5.2040
• Hartman K, Geraci E, Spencer J, Kukla M, Acquisto NM, Hutchinson DJ. Evaluation of risk factors associated with acute kidney injury in a level IV regional NICU. J Neonatal Perinatal Med. 2024;17(6):787-794. https://doi.org/10.1177/19345798241310117
• Hintze TD, Downing JV, Acquisto NM, et al. Metoprolol vs diltiazem for atrial fibrillation with rapid ventricular rate: systematic review and meta-analysis of adverse events. Am J Emerg Med. 2025;89:230-240. https://doi.org/10.1016/j.ajem.2024.12.070
• Kaucher K, Acquisto NM, Lowrey K, Gilliam E, Buchanan J, Metz M. Improvement in HIV screening follow-up rates with emergency department pharmacist dispensing and counseling of post-exposure prophylaxis. JAPhA Pract Innov. 2025;2(1):100025. https://doi.org/10.1016/j.japhpi.2024.100025
• Uttaro E, Hopkins A, Kokanovich K, Maynard K, Vella M, Jones CMC, Miglani A, Acquisto NM. Feasibility of trauma video review (TVR) for the collection of medication-related information for research and quality improvement. Am J Health Syst Pharm. 2024 Oct 12. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae301
• Bailey AM, Weant KA. Dream of the endless: updates in agents for procedural sedation. Adv Emerg Nurs J. 2024;46(3):195-206. https://doi.org/10.1097/TME.0000000000000528
• Hays WB, Billups K, Nicholson J, Bailey AM, Gregory H, Weeda ER, Weant KA. 3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors. J Thromb Thrombolysis. 2025;58(2):276-283. https://doi.org/10.1007/s11239-024-03052-4
• Robbins B, Almassalkhi L, Baum R, Blackburn M, Davis J, Edwards L, Hile G, Olney W, Weant K, Metts E. Pharmacotherapy adjuncts for traumatic brain injury: a narrative review of evidence and considerations in the emergency department. Am J Emerg Med. 2025;89:78-84. https://doi.org/10.1016/j.ajem.2024.12.004
• Gilbert BW, Bissell Turpin BD. Complexities of evidence-based medicine: challenges for practice and policy development. Am J Health Syst Pharm. 2025;82(6):359-363. https://doi.org/10.1093/ajhp/zxae253
• Aljadeed R, Gilbert BW, Karaze T, Rech MA. Intravenous push administration of anti-seizure medications. Front Neurol. 2025;15:1503025. https://doi.org/10.3389/fneur.2024.1503025
• Houston AJ, Wilson CS Jr, Gilbert BW. Antiseizure medication practices in the adult traumatic brain injury patient population. Am J Emerg Med. 2024;86:125-128. https://doi.org/10.1016/j.ajem.2024.10.009
• Murray DS, Gilbert BW, Cox TR. Pilot study on the impact of early subcutaneous basal insulin administration in diabetic ketoacidosis. J Intensive Care Med. 2024;39(10):980-984. https://doi.org/10.1177/08850666241247516
• Townsend BR, Malka ST, Di Paola SG, Nisly AE, Gilbert BW. DRopEridol for abdominal pain in the emergency department for morphine equivalent reduction. The DREAMER study. Am J Emerg Med. 2025;90:31-34. https://doi.org/10.1016/j.ajem.2024.12.082
• Groth CM, Droege CA, Sarangarm P, Cucci MD, Gustafson KA, Connor KA, Kaukeinen K, Acquisto NM, Chui SHJ, Dixit D, Flannery AH, Glass NE, Horng H, Heavner MS, Kinney J, Peppard WJ, Newsome AS, Viswesh V, Erstad BL. Multicenter retrospective review of ketamine use in pediatric intensive care units (Ketamine-PICU Study). Crit Care Res Pract. 2024;6626899. https://doi.org/10.1155/2024/6626899
• Weant KA, Acquisto NM, Brown M, Luppa J, Rappaport S, Weeda E. Developing a pharmacy residency research program educational series: a review of the literature and considerations for implementation. Am J Health Syst Pharm. 2024 Dec 10. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae382
• Weant KA, Bailey AM. Dream of the endless: special considerations in procedural sedation. Adv Emerg Nurs J. 2025;47(1):13-22. https://doi.org/10.1097/TME.0000000000000546

Presentations

• Kevin Mercer: Critical care & emergency medicine pharmacotherapy for physical therapists. Presented at: American Physical Therapy Association Combined Sessions Meeting; February 2025; Houston, TX.

Other Notable Achievements

• Angela Antoniello:
  • New PGY2 Critical Care Pharmacy Residency Program Director, Cooperman Barnabas Medical Center, Livingston, NJ.
  • ACCP EMED PRN Media Co-Chair.
• Heather Blue:
  • Board of Pharmacy Specialties BCEMP Job Analysis Panel Member.
  • BCEMP.
• Deborah Booth: Hospital Emergency Response Training and Train-the-Trainer Center for Domestic Preparedness, FEMA.
• Jennifer Lee: SCCM Clinical Pharmacy & Pharmacology Section Membership Committee Chair.
• Kevin Mercer:
  • BCEMP.
  • Board of Pharmacy Specialties BCEMP Job Analysis Panel Member.
• Lance Ray: Board of Pharmacy Specialties BCEMP Job Analysis Panel Member.
• Megan Rech:
  • Society for Academic Emergency Medicine (SAEM) Academic Emergency Medicine Pharmacists (AEMP) Interest Group Inaugural Chair.
  • Society of Critical Care Medicine (SCCM) Clinical Pharmacy & Pharmacology (CPP) Section Chair.
• Alyssa Robertson:
  • New PGY2 Emergency Medicine Pharmacy Residency Program Director, WellSpan York Hospital, York, PA.
  • Board of Pharmacy Specialties BCEMP Job Analysis Panel Member.
• Haley Watson: BCEMP.
• Kyle Weant: BCEMP.
• Lauren Wright:
  • New PGY2 Emergency Medicine Pharmacy Residency Program Director, Baptist Medical Center South, Montgomery, AL.
  • Board of Pharmacy Specialties BCEMP Job Analysis Panel Member.

Endocrine and Metabolism PRN

Promotions

• Sara (Mandy) Reece: Dean and Chief Academic Officer, PCOM Georgia School of Pharmacy.

 Publications

• Aguiniga A, Baalmann A, Challen L, Lingow S, Marrs J, Painter N, Riccio K, Salama L, Sherrill CH, Van Dril E, Wesling M, Westberg S, Wheeler SE (as part of the Advancing Pharmacist Payment Parity Workgroup). State of the union: a review of state-based laws and regulations supporting pharmacist payment for clinical services. J Am Coll Clin Pharm. 2024;7(9):908-925. https://doi.org/10.1002/jac5.2008
• Aguiniga A, Ebert D, Rodriguez E, Nguyenly A, Wesling M. The effect of chronic care management on diabetes-related outcomes in interprofessional care of a medically complex patient population. J Am Coll Clin Pharm. 2024 Sep 4. [Epub ahead of print] https://doi.org/10.1002/jac5.2024
• Palasik Torres B, Aguiniga A, Yzaguirre S, Thompson SR, Wesling M. Trends and considerations in the pursuit of postgraduate training: motivations, barriers, and well-being. Am J Health Syst Pharm. 2025 Jan 4. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae368
• Pizzutelli N, Maerten-Rivera J, Albanese N, et al. Assessment of student well-being and identification of associated factors. Curr Pharm Teach Learn. 2025;17:102298. https://doi.org/10.1016/j.cptl.2025.102298
• Carson E, Vernon V, Cunningham L, Mathew S. Cooling the flames: navigating menopausal vasomotor symptoms with nonhormone medications. Am J Health Syst Pharm. 2024 Sep 7. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae254
• Reid DJ. PREVENTing CKM syndrome. ADCES Pract. 2025 Jan 16. [Epub ahead of print] https://doi.org/10.1177/2633559X241306148
• Balata S, Chiang J, Hassan A, Reid DJ. Expanding use of continuous glucose monitoring in type 2 diabetes. ADCES Pract. 2025;13(1):8-15. https://doi.org/10.1177/2633559X241296156
• Schumacher C. Why I became a diabetes care and education specialist? ADCES Pract. 2025;13(1):32-33. https://doi.org/10.1177/2633559X241291873
• Landup D, Schumacher C, Van Dril E. Pharmacist’s role in heart failure management. In: Evoy KE, ed. ACCP Ambulatory Care Pharmacist’s Survival Guide. 5th ed. American College of Clinical Pharmacy; 2024:147-164.
• Folz HN, Lee S, Sherrill CH. Student pharmacist counseling performance after hands-on continuous glucose monitoring education: a multi-institutional pragmatic randomized study. Patient Educ Couns. 2025;131:108578. https://doi.org/10.1016/j.pec.2024.108578
• Hwang AY, Sherrill CH. Hypertension. Pharmacotherapy Self-Assessment Program Book 1 (Cardiology). American College of Clinical Pharmacy; 2025:1-26.
• Litten K, Folz H, Lobkovich A, Sherrill CH, Berlie H. Integrating continuous glucose monitoring into doctor of pharmacy curricula. J Am Coll Clin Pharm. 2025;8(2):129-135. https://doi.org/10.1002/jac5.2076
• Van Dril E, Schumacher C. Hypertension medication management protocol. In: Evoy KE, ed. ACCP Ambulatory Care Pharmacist’s Survival Guide. 5th ed. American College of Clinical Pharmacy; 2024:115-127.
• Van Dril E, Wesling M, Petrie JL. Pharmacist billing and reimbursement resource guide. In: Evoy KE, ed. ACCP Ambulatory Care Pharmacist’s Survival Guide. 5th ed. American College of Clinical Pharmacy; 2024:13-27.
• Wilcox L, Van Dril E. Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous glucagon-like peptide-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine case report. J Am Pharm Assoc (2003). 2024;64(6):102185. https://doi.org/10.1016/j.japh.2024.102185

 Presentations

• Nicole P. Albanese:
  • Exploring medication options for adult and adolescent obesity. Presented at: ASHP 2024 Midyear Clinical Meeting and Exhibition; December 11, 2024; New Orleans, LA.
  • Complementary medicine in 2024 and conversations about vitamins with patients. Presented at: 2024 ACCP Annual Meeting; October 15, 2024; Phoenix, AZ.
• Nicole P. Albanese, Alaina Van Dyke, Sarah A. Kain: Endocrine and Metabolism PRN focus session: navigating optimal medication strategies and deprescribing in the landscape of intensive therapeutic lifestyle changes for persons with type 2 diabetes. Presented at: 2024 ACCP Annual Meeting; October 13, 2024; Phoenix, AZ.
• Helen Berlie, Christy Sherrill: Multi-institutional approaches to incorporating continuous glucose monitoring (CGM) into pharmacy education. Presented at: Collaborative AACP webinar presented with the Technology in Pharmacy Education and Practice SIG and the Curriculum SIG; February 10, 2025; virtual.
• Lauren Cunningham: Possible cholelithiasis linked to liraglutide and safe subsequent use of semaglutide and tirzepatide without cholecystectomy: a case report. Poster presented at: 2024 ACCP Annual Meeting; October 13, 2024; Phoenix, AZ.
• Sumana (Mimi) Mukherjee: Impact of a remediation plan in a pharmacotherapeutics course series. Presented at: American Association of Colleges of Pharmacy; July 2024; Boston, MA.
• Christie Schumacher
  • Navigating diabetes medication transitions: strategies for smooth transitions and client support. Presented at: Food & Nutrition Conference & Expo; October 2024; Minneapolis, MN.
  • Using continuous glucose monitoring to advance cardiometabolic kidney care. Presented at:
    • Association of Diabetes Care and Education Specialists Illinois, Indiana, Iowa and Missouri Midwest Connect Annual Diabetes Symposium; November 2024; Normal, IL.
    • Association of Diabetes Care and Education Specialists South Carolina 36th Annual Diabetes Conference: Mission: Possible—Agents for Change; November 2024; Columbia, SC.
    • Association of Diabetes Care and Education Specialists 27th Annual Montana Diabetes Professional Conference; October 2024; Fairmont, MT.
  • Use of diabetes medications in the management of non-diabetes conditions. Presented at:
    • Association of Diabetes Care and Education Specialists South Carolina 36th Annual Diabetes Conference: Mission: Possible—Agents for Change; November 2024; Columbia, SC.
    • Association of Diabetes Care and Education Specialists Oregon and Washington Annual Conference: Seas the Days!; October 2024; Seaside, OR.
  • Keeping up with the kidney: updates in the management of chronic kidney disease in people with diabetes. Presented at:
    • Association of Diabetes Care and Education Specialists Maine and New Hampshire Annual Diabetes Conference: Diabetes from Top to Bottom; October 2024; Rochester, NH.
    • Association of Diabetes Care and Education Specialists Chicago Local Networking Group; October 2024; Chicago, IL.Association of Diabetes Care and Education Specialists 27th Annual Montana Diabetes Professional Conference;
    • October 2024; Fairmont, MT.
    • Association of Diabetes Care and Education Specialists Colorado Annual Conference: Diabetes from Head to Toe; September 2024; Denver, CO.
  • Sick days, smart ways: navigating diabetes management during illness. Presented to: health care professionals in Utah working with the Association for Utah Community Health; September 2024; virtual.
• Elizabeth Van Dril, John Shilka: Module 9: selected measures for pharmacy professionals—part 3, subsection: quality measures related to outpatient diabetes management. In: Quality Improvement for Pharmacy Professionals Certificate. American Society of Health-System Pharmacists; August 2024; virtual.
• Carrie Yu, Christie Schumacher, Elizabeth Van Dril: Describing current practices and barriers to pharmacist-led outpatient glucagon use in people with diabetes. Vizient Pharmacy at American Society of Health-System Pharmacists Midyear Clinical Meeting Poster Session; December 2024; New Orleans, LA.

New ACCP Fellows

• Nicole Paolini Albanese
• John D. Bucheit
• Nicholas W. Carris
• Laura M. Challen
• Rebecca A. Maxson
• Krystal KC Riccio
• Christina H. Sherrill

Other Notable Achievements

• Lauren Cunningham: Appointed as Assistant Director of Postgraduate Year 2 (PGY-2) Ambulatory Care Residency Program, University of Illinois Chicago Retzky College of Pharmacy.
• Christie Schumacher:
• Elected to serve on the American Diabetes Association Journal, Clinical Diabetes, Editorial Board (January 2025).
• Served as the Guest Editor for the Journal of the American College of Clinical Pharmacy (JACCP) Diabetes Themed Issue.
• Elizabeth Van Dril: Appointed as Chair of ACCP 2025 Annual Meeting Program Committee.

Geriatrics PRN

Promotions

• Donna M. Lisi: Clinical Pharmacist, Independent Consultant.
• Mary Beth O’Connell: Professor, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences.
• L. Michael Posey: President, Pharmacy Editorial & News Services.
• Linda Sobeski: (Inaugural) Associate Dean for the Kearney Campus, University of Nebraska College of Pharmacy.
• Michael Zanchelli: Advanced Pharmacy Fellow in Geriatrics, Department of Veteran Affairs.

 Awards

• Donna M. Lisi: County Volunteer of the Year, New Jersey Governor’s Council on Substance Use Disorder.

 Grants

• Sum Lam: Community Engaged Learning Grant 2024-2025. St John’s University, Queens, NY.

 Publications

• Gordon NN, Christenberry EJ, Smith SC, et al. Don’t worry, be APPE: developing and refining a skills-based assessment of student preparedness for advanced pharmacy practice experiences. Curr Pharm Teach Learn. 2025;17(1):102204. https://doi.org/10.1016/j.cptl.2024.102204
• Lam S, El-Chaar G. Urinary incontinence and pediatric enuresis. In: Wells B, et al. Pharmacotherapy Principles and Practice. 7th ed. McGraw-Hill. In press.
• Lam S, Nawarskas J, Cheng-Lai A. Anemia and preventive therapy. In: Hutchison L, Sleeper RB, eds. Fundamentals of Geriatric Pharmacotherapy: An Evidence-Based Approach. 3rd ed. American Society of Health-System Pharmacists. In press.
• Lisi DM. AI for preventing and detecting adverse drug events. US Pharm. 2025;50:32-37. https://www.qgdigitalpublishing.com/publication/?i=839591&p=46&view=issueViewer
• Lisi DM. COVID-19 vaccine safety update. US Pharm. 2024;49:39-46. https://www.qgdigitalpublishing.com/publication/?i=832016&p=57&ver=html5
• O’Connell MB, DeLellis T. Musculoskeletal and connective tissue disorders. In: Hutchison L, Sleeper RB, eds. Fundamentals of Geriatric Pharmacotherapy: An Evidence-Based Approach. 3rd ed. American Society of Health-System Pharmacists. In press.
• Marcath M, Craig K, O’Connell MB. Impact of reproductive health education seminars on college students’ contraception and safe sex knowledge and behaviors. Pharmacy. 2025;13(2):39. https://doi.org/10.3390/pharmacy13020039
• Posey LM. Higher education and aging: the age-friendly movement—building a case for age inclusivity. what’s hot: a Newsletter of the Gerontological Society of America. https://gsaenrich.geron.org/age-inclusivity-in-higher-education
• Hossain SR, Samant AN, Balsamo BC, Hawley CE, Zanchelli MC, Zhu C, et al. Effect of medication management at home via pharmacist-led home televisits: protocol for a cluster randomized controlled trial. JMIR Res Protoc. 2025;14:e65141. https://doi.org/10.2196/65141

 Other Notable Achievements

• Sum Lam: Chair-Elect 2024-2025, Geriatrics Practice and Research Network (PRN), American College of Clinical Pharmacy (ACCP).
• Donna M. Lisi: Fellow, American Association of Psychiatric Pharmacists.

GI/Liver/Nutrition PRN

Awards

• Sarah Cogle: Vanderbilt University Medical Center Adult Inpatient Pharmacy Medication Safety Award.
• Michael Rudoni: SCCM Presidential Citation, Society of Critical Care Medicine.
• Jason Yerke: Publication of the Year, ACCP Critical Care PRN.

 Publications

• Asal NJ, Sibicky S, Sittard L. Renal and urologic disorders. In: Hutchinson LC, Sleeper RB, eds. Fundamentals of Geriatric Pharmacotherapy: An Evidence-Based Approach. American Society of Health-System Pharmacists; 2025. In press.
• Patel KS, Sacha GL, Torbic H, Bass S, Wang L, Duggal A, Rudoni MA. Evaluation of response to weight-based dosing strategies of continuous, fixed-rate atracurium infusions in critically ill, obese adults with acute respiratory distress syndrome. Ann Pharmacother. 2024 Dec 18. [Epub ahead of print] https://doi.org/10.1177/10600280241304406
• Cogle SV, Hallum M, Mulherin DW. Applying the 2022 ASPEN adult nutrition support guidelines in a 2024 ICU. Nutr Clin Pract. 2024;39:1055-1068. https://doi.org/10.1002/ncp.11188
• Jagasia P, Ladele O, Slutsky H, Troche M, Cogle SV, Strock E, et al. Volume-based feeds: a quality improvement project for better nutrition. J Burn Care Res. 2024;45:1520-1526. https://doi.org/10.1093/jbcr/irae163
• Martindale RG, Calder PC, Cogle SV, et al. Lipids in parenteral nutrition-expert consensus statements: translating guidelines into clinical practice. Clin Nutr Open Sci. 2025;60:50-65. https://doi.org/10.1016/j.nutos.2025.01.004
• Chen B, Iqbal U, Desai SK, Gries J, Verheyen E, Xie M, El Halabi M, Gaines S, et al. The role of treatment of hepatitis C with direct-acting antiviral agents on glycaemic control in diabetic patients: an updated systematic review and meta-analysis. J Viral Hepat. 2024;31(10):633-642. https://doi.org/10.1111/jvh.13984
• Persaud P, Rudoni MA, Duggal A, Miyashita S, Lanspa M, Dugar S. Validity of International Classification of Diseases, Tenth Revision, codes for atrial fibrillation/flutter in critically ill patients with sepsis. Anaesth Crit Care Pain Med. 2024;43(4):101398. https://doi.org/10.1016/j.accpm.2024.101398

 Presentations

• Sarah Cogle
  • Anti-Xa monitoring for venous thromboembolism prophylaxis in patients with burn injuries. Presented at: Society of Critical Care Medicine Congress; February 23, 2025; Orlando, FL.
  • Evaluation of a weight-based venous thromboembolism prophylaxis protocol in burn patients. Presented at: Society of Critical Care Medicine Congress; February 23, 2025; Orlando, FL.
  • From past to present: updating parenteral nutrition practices in critical care. In: Don’t Be Ir-RATION-al with Parenteral Nutrition Use: Enhancing Safety from Prescribing to Transitions of Care. Presented at: ASHP Midyear Clinical Meeting; December 10, 2024; New Orleans, LA.
  • Incidence of selenium deficiency in patients with significant burn injuries. Presented at: Society of Critical Care Medicine Congress; February 24, 2025; Orlando, FL.
• Michael Rudoni
  • CTRL + ALT + teach: AI and the future of healthcare education. Presented at: Society of Critical Care Medicine Congress; February 24, 2025; Orlando, FL.
  • Incorporating resilience, wellness, and self-care into critical care training and practice. Presented at: Society of Critical Care Medicine Congress; February 25, 2025; Orlando, FL.

 Other Notable Achievements

• Sarah Cogle: Fellow of Critical Care Medicine.
• Michael Rudoni:
  • Fellow of Critical Care Medicine.
  • President, SCCM Ohio Chapter.

Global Health PRN

Awards

• Lauren Jonkman: Distinguished Pharmaceutical Educator (mid-career), International Pharmaceutical Federation (FIP).

 Promotions

• Hanna Rotundo: Clinical Associate Professor, University of Louisiana Monroe College of Pharmacy.

Publications

• Bhuiyan J, Arellano R, Carroll DG, Chim C, Connor S, Dang DK, Draime JA, Driscoll TP, Jonkman L, et al. COEPA ready: innovative pedagogy for integrating social determinants of health in PharmD curricula. Curr Pharm Teach Learn. 2025;17(2):102267. https://doi.org/10.1016/j.cptl.2024.102267
• Ndung’u M, Babalola R, Brand M, Patel R. Impact of continuous glucose monitoring in underserved adults with type 2 diabetes within the United States: a scoping review. J Am Coll Clin Pharm. 2025;8(2):149-162. https://doi.org/10.1002/jac5.2078

Presentations

• Martha Ndung’u:
  • Educators’ summit—responding to a call for innovation in pharmacy education and training. Presented at: International Pharmaceutical Federation 82nd World Congress of Pharmacy and Pharmaceutical Sciences; September 4, 2024; Cape Town, South Africa.
  • CGM use in underserved populations. Presented at: Pennsylvania Pharmacists Association Conference; February 14, 2025; Harrisburg, PA.

New ACCP Fellows

• Veena Venugopalan

Other Notable Achievements

• Deanna J. Laughlin:
  • Selected as the APhA Ton Hoek Scholarship Recipient to attend FIP this September.
  • Selected as Student Exchange Officer-Elect for the APhA International Standing Committee.
• Martha Ndung’u: 30 Under 30 by Pittsburgh Business Times.

Health Equity PRN

The Health Equity PRN warmly congratulates its members on their accomplishments. We look forward to implementing our educational, research, and mentorship initiatives. As the PRN expands, we look forward to opportunities to collaborate and more ways to engage our members. Please reach out to us if you have any questions or ideas to promote health equity in our profession.

Promotions

• John M. Allen: Department Head of Pharmacy Practice, Purdue University College of Pharmacy, West Lafayette, IN.
• Maria Florencia Zaller: Senior Clinical Pharmacist, Health Equity and Ambulatory Care for California at Providence Facey, Mission Hills, CA.

Awards

• Melissa Santibañez:
  • SCCM Presidential Citation Award. Society of Critical Care Medicine (SCCM) Critical Care Congress; February 2025; Orlando, FL.
  • Gold Ribbon Abstract Award for “Evaluating the impact of a training-based program on social determinants of health for healthcare professionals.” Academy of Managed Care Pharmacy; December 2024.
  • External Funding Recognition Award (Fiscal Year 2024), Nova Southeastern University; November 2024.
• Maria Florencia Zaller: VIA (Value in Action) Award, Providence, OR.

Grants

• Darra M. Edwards: Implementing Health-at-Home Community Pop-Up Clinics: Closing Gaps, Building Trust, and Improving Healthcare Access Among Adults Under Age 65 with Undiagnosed and/or Uncontrolled Hypertension and Diabetes. Alliance for Academic Internal Medicine (AAIM) grant. Co-Principal Investigator ($20,000).
• Omolola (Lola) Olatunde:
  • Pharmacy Advances Clinical Trials (PACT) Network. American Association of Colleges of Pharmacy. Implementation Scientist & Consultant ($30,000).
  • Community Engagement and Implementation Science Approaches to Meaningfully Mitigate Health Disparities Among Racial and Ethnic Minority Groups and Individuals with Lower Socioeconomic Status. NIH—National Institute on Minority Health and Health Disparities (NIMHD). Principal Investigator ($100,000).
  • Co-Designing a Toolkit for Inclusive Shared Decision-Making Processes to AcceleRate Early Detection of Alzheimer’s Disease in Diverse Communities (SHARE-D). Neuroscience Institute. Co-Principal Investigator ($25,000).
  • Improving Nutrition Education at an Indianapolis Food Pantry. Indiana Department of Health—St. Vincent DePaul. Co-Investigator ($53,326).
• Sonak Pastakia:
  • Establishing Vocational Training for Street Youth. Chaney Family Grant. Co-Principal Investigator ($50,000).
  • Peers and Technology for Adherence (PT4A). National Heart, Lung, and Blood Institute (NHLBI) R01. Co-Investigator ($3,120,000).
  • Bridging the Treatment Gap by Expanding Access to Care for People with Epilepsy in Kenya (BEACON). NIH Grant. Co-Investigator ($3,134,427).
  • Development of a Comprehensive Wellness Program for Vulnerable Young Mothers and Children at Tumaini Innovation Center. Engaged Scholarship Research/Creative Activities Grants Program. Co-Investigator ($5000).

 Publications

• Adeoye-Olatunde OA, Hastings T, Blakely M, Boyd L, Aina A, Sherbeny F. Social determinants of health and medication adherence in older adults with prevalent chronic conditions in the United States: an analysis of the National Health and Nutrition Examination Survey (NHANES) 2009-2018. Pharmacy. 2025;13(1):20. https://doi.org/10.3390/pharmacy13010020
• Casbon KA, Gatting KJ, Nadig S, Peckinpaugh IK, Sauquet AA, Byrd KAD, Conklin ME, Garcia G, Struewing ML, Adeoye-Olatunde OA. Assessing the reach of health access resources in Indianapolis for populations with low income. Purdue J Serv Learn Int Engagement. 2024;11(1):13. https://doi.org/10.7771/2331-9143.1412
• Chan CK, Lane KA, Gao S, Adeoye-Olatunde OA, Biber S, Glover CM, et al. Referral source across racial and ethnic groups at Alzheimer’s disease research centers. J Alzheimers Dis. 2024;101(4):1167-1176. https://doi.org/10.3233/JAD-240485
• Noureldin M, Coe AB, DeLellis T, Clifford KM, Freire-Cobo C, Reilly M, Campbell AM, Nagy MW, Adeoye-Olatunde OA, et al. The state of the academic pharmacy workforce specializing in geriatrics. Gerontol Geriatr Educ. 2025 Feb 19. [Epub ahead of print] https://doi.org/10.1080/02701960.2025.2466199
• Richards R, Richards M, Musema J, Tackett A, Van Heiden S, Polsinelli A, Gao S, Brown SA, Unverzagt FW, Risacher S, Adeoye-Olatunde O, et al. Developing and applying potentially scalable recruitment strategies to accelerate ADRD research participation of Black adults. Alzheimers Dement. 2024;21(2):e14440. https://doi.org/10.1002/alz.14440
• Arif S. Shift: A Practical Guide to Cultivating Equity and Inclusion in Healthcare Education. Global Bookshelves International, LLC; 2024
• Devraj R. Covvey, J, Arif S. Bridging the digital divide: the importance of techquity in pharmacy education. Am J Pharm Educ. 2025. In press.
• Llayton C, Ray ME, Arnoldi J, Arif S, Edwards A, Hall L, et al. Infrastructure and resourcing of diversity, equity, inclusion, and accessibility initiatives across US pharmacy schools. Curr Pharm Teach Learn. 2024;17(3):102242. https://doi.org/10.1016/j.cptl.2024.102242
• Crowe S, Kimiecik C, Adeoye-Olatunde OA, Conklin M, Smith J, Pastakia SD, et al. Social determinants of health-based strategies to address vaccination disparities through a university-public health partnership. J Clin Transl Sci. 2024;8(1):e66. https://doi.org/10.1017/cts.2024.502
• Ihns K, Starr K, Marchand C, Jaimon J, Singer A, Hassoun L, et al. Evidence of commonly used integrative approaches with pharmacotherapy for chronic pain management. J Pain Palliat Care Pharmacother. 2024;38(3):302-317. https://doi.org/10.1080/15360288.2024.2390999
• Marcath M, Craig K, O’Connell MB. Impact of #PlanA reproductive health seminars on college students’ contraception and safe sex knowledge and behaviors. Pharmacy. 2025;13(2):39. https://doi.org/10.3390/pharmacy13020039
• O’Connell MB, DeLellis T. Musculoskeletal and connective tissue. In: Sleeper R, Hutchinson L, eds. Fundamentals of Geriatric Pharmacotherapy: An Evidence-Based Approach. 3rd ed. American Society of Health-System Pharmacists; 2025:483-526.
• Pastakia SD, Schutz H, Tiruneh T, Gordillo De Vivero A, Dodds L. Observational assessment of the utilization of donated point of care tests and glycemic control at free and charitable clinics across the United States. Pract Lab Med. 2025;44:e00450. https://doi.org/10.1016/j.plabm.2025.e00450
• Ardehali M, Kafu C, Vazquez Sanchez M, Wilson-Barthes M, Mosong B, Pastakia SD, Said J, Tran DN, et al. Food insecurity is associated with greater difficulty accessing care among people living with HIV with or without comorbid non-communicable diseases in western Kenya. BMJ Glob Health. 2024;9(12):e016721. https://doi.org/10.1136/bmjgh-2024-016721
• Chay J, Su RJ, Kamano JH, Andama B, Bloomfield GS, Delong AK, Horowitz CR, Menya D, Mugo R, Orango V, Pastakia SD, et al. Cost-effectiveness of group medical visits and microfinance interventions versus usual care to manage hypertension in Kenya: a secondary modelling analysis of data from the Bridging Income Generation with Group Integrated Care (BIGPIC) trial. Lancet Glob Health. 2024;12(8):e1331-e1342. https://doi.org/10.1016/S2214-109X(24)00188-8
• Saravanan P, Deepa M, Ahmed Z, Ram U, Surapaneni T, Kallur SD, Desari P, Suresh S, Anjana RM, Hannah W, Shivashri C, Hemavathy S, Sukumar N, Kosgei WK, Christoffersen-Deb A, Kibet V, Hector JN, Anusu G, Stallard N, Ghebremichael-Weldeselassie Y, Waugh N, Pastakia SD, et al. Early pregnancy HbA_1c as the first screening test for gestational diabetes: results from three prospective cohorts. Lancet Diabetes Endocrinol. 2024;12(8):535-544. https://doi.org/10.1016/S2213-8587(24)00151-7
• Santibañez M, Boylan PM, Paloucek FP, Caballero J. The social media “expert” phenomenon: need for increased pharmacy practice transparency. Front Commun (Lausanne). 2024;9:1467468. https://doi.org/10.3389/fcomm.2024.1467468
• Santibañez M, Rincon-Ponte AM, Sastre Perez G. Antimicrobial stewardship principles for critically ill patients. AACN Adv Crit Care. 2025;36:5-13. https://doi.org/10.4037/aacnacc2025715
• Boylan PM, Santibañez M, Thomas J, Weeda E, Noel Z, Caballero J. Cannabinoids for obstructive sleep apnea: a systematic review. Pharmacotherapy. 2024;44:880-891. https://doi.org/10.1002/phar.4622
• Singh-Franco D, Pham H, Metzner M, Santibañez M. Resmetirom for moderate to advanced liver fibrosis: a new drug for an old problem! ACCP Ambulatory Care PRN Newsletter. 2024:12-18.
• Wilson-Barthes M, Steingrimsson J, Lee Y, Tran DN, Wachira J, Kafu C, Pastakia SD, et al. Economic outcomes among microfinance group members receiving community-based chronic disease care: cluster randomized trial evidence from Kenya. Soc Sci Med. 2024;351:116993. https://doi.org/10.1016/j.socscimed.2024.116993

 Presentations

• Sally Arif:
  • Prescribing progress: revolutionizing pharmacy residencies through diversity, equity, and inclusion excellence. Presented at: American Society of Health-System Pharmacists Preceptor Meeting; October 3, 2024; virtual.
  • 7 strategies to create an equity-minded learning environment. Presented at: Marshall Ketchum University-Inclusion, Diversity, Equity, Antiracism (IDEA) Speaker Series; February 19, 2025; virtual.
  • Longing for belonging: cultivating an inclusive and accepting environment for all. Presented at: 2024 ACCP Annual Meeting; October 12, 2024; Phoenix, AZ.
• Darra Edwards: Closing the gaps within health disparity: priorities and partnerships. Panelist speaker at HealthTrust University (HTU) Conference; August 14, 2024; Orlando, FL.
• Jerika Nguyen: Critical Care PRN development of a themed issue for Pharmacotherapy publications. Presented at: 2024 ACCP Annual Meeting; October 15, 2024; Phoenix, AZ.
• Omolola (Lola) Olatunde:
  • Developing and applying potentially scalable recruitment strategies to accelerate dementia research participation of Black adults. Poster presented at: Alzheimer’s Association International Conference (AAIC) Advancements Exploring Equity in Diagnosis; November 2024; Chicago, IL.
  • Coach-led mobile health intervention for hypertension management in Nigeria. Poster presented at: College of Pharmacy Research Day; November 2024; West Lafayette, IN.
  • Assessing the Indiana health equity council community health worker model: a collaborative study. Poster presented at: College of Pharmacy Research Day; November 2024; West Lafayette, IN.
  • Giving and receiving feedback. Invited panelist at: Women in Pharmacy Webinar; October 2024; virtual.
• Sharmon P. Osae: ACE’ing healthcare: always consider equity whilst delivering patient care and precepting. Presented at: Tomah WI VAMC Grand Rounds; December 2, 2024; virtual.
• Sonak Pastakia: The pharmacist’s role in policy making & community collaboration Global Health PRN focus session podium presentation—pharmacist collaboration in global health: building partnerships for impact. Presented at: 2024 ACCP Annual Meeting; October 12, 2024; Phoenix, AZ.
• Melissa Santibañez:
  • Systemic steroid dosing practices for acute exacerbations of chronic obstructive pulmonary disease. Research snapshot. Presented at: SCCM Critical Care Congress; February 2025; Orlando, FL.
  • Evaluation of clinical outcomes of midodrine on IV vasopressor requirements in critically ill adults. Research snapshot. Presented at: SCCM Critical Care Congress; February 2025; Orlando, FL.
• Daphne Smith Marsh: Reimagining cultural terms: embracing cultural humility in health care: CE program. Presented at: University of Illinois, Chicago (UIC) Retzky College of Pharmacy; March 5, 2025; Chicago, IL.
• Maria Florencia Zaller:
  • Closing the gap: enhancing HTN control in LatinX communities through provider referrals. Presented at: Adult Medicine Monthly Meeting for Providence Facey; November 14, 2024; Mission Hills, CA.
  • Enhancing hypertension treatment compliance: the impact of cultural competence on BIPOC communities. Presented at: Providence Facey; March 12, 2025; Mission Hills, CA.
  • SBAR for social determinants of health (SDOH): provide pharmacy ambulatory care teams a standardized process for capturing and documenting SDOH(s) intervention during pharmacy driven disease management program encounters in EPIC through discrete extractable data points. Presented at: Providence Facey; October 10, 2024; virtual.

 Other Notable Achievements

• Jenna Cox: Fellow, Society of Critical Care Medicine (February 2025).
• Darra M. Edwards:
  • Featured in speaker series article, “What’s on pharmacy leaders’ radars for 2025,” Becker’s Healthcare Spring Chief Pharmacy Officer Summit. December 23, 2024.
  • Featured in article, “Leveling the playing field: experts weigh in on making healthcare delivery fair game for all populations.” The Source. Q4 2024;18(4):26-28, 32. HealthTrust Performance Group 2024.
• Kelsey Ihns:
  • ACCP Trainee Enrichment Subcommittee Chair.
  • ACCP Health Equity PRN Steering Committee Member.
  • ACCP Health Equity PRN Research and Scholarship Subcommittee Member.
  • HRSA Opioid Impact Family Support Specialist.
• Jerika Nguyen:
  • Education Committee Chair, SCCM Michigan Chapter.
  • Multiprofessional Critical Care Review and Assessment: Adult Committee, SCCM.
  • Guest Editorial Board, JACCP Critical Care Themed Issue.
• Melissa Santibañez: Graduate of ACCP Professional Leadership Development Program, 2023-2024 cohort (Phoenix, AZ); October 2024.
• Daphne Smith Marsh:
  • Internal Faculty Publication: Smith Marsh DE. Promote Success and Equity with Inclusive Language. TALK Tips. University of Illinois Chicago College of Pharmacy. January 2025
  • Television appearances: Chicago Access Network Television (CAN-TV 21) Guest House monthly program. September 2024.
  • Featured health care professional, providing general information regarding diabetes and social determinants of health.
  • Inflation Reduction Act press conference at UIC Retzky College of Pharmacy with Senator Richard (Dick) Durbin regarding the updates for expanded medication coverage.
  • Pharmacist/Diabetes Educator representative. September 2024.
• Maria Florencia Zaller:
  • Implemented and in charge of a new HTN Care Program Pharmacy Driven Clinic for LatinX patients.
  • Developed, implemented, and launched a new Community Health Worker (CHW) workflow for all Providence Ministries (including Los Angeles, CA; Orange County, CA; High Desert, CA; Mission Hills, California, Northern California).
  • Developed and implemented training material and training expectation for all new CHW onboarding.
  • Developed, implemented, and launched all EMR documentation for CHW workflow and pharmacy workflow as it relates to Health Equity Efforts (via EPIC). Includes both workflow documentations, patient letters in both Spanish and English.
  • Developed and implemented patient education resources for HE HTN clinic for Southern and Northern California.
  • Developed/created all patient flyers to be used in California for HE equity efforts in both Spanish and English.
  • Developed (soon to be implemented) additional EPIC/EMR pharmacy-related intervention items that would allow extractable data as is related to Social Driver of Health Pharmacy Interventions (ie, completion of risk assessment and patient resource provision).
  • Developed, implemented, manage and continue to Publish Monthly Newsletter: Health Equity Ambulatory Care Disease Management Newsletter monthly/bimonthly, which is shared with California.
  • Obtained the following new certifications: ASHP DEI certificate, ASHP Pharmacy Leadership Certificate, and HFSA (Heart Failure Society of America) certificate, Advanced Practice Pharmacist License.

Health Outcomes PRN

Promotions

• Duncan Dobbins: National Chair of ACCP’s Resident Advisory Committee.

Publications

• Baker WL, Moore T, Baron E, Kittleson M, Parker WF, Jaiswal A. A systematic review of reporting and handling of missing data in observational studies using the UNOS database. J Heart Lung Transplant. 2025;44(3):462-468. https://doi.org/10.1016/j.healun.2024.10.023
• Bozkurt B, Ahmad T, Alexander K, Baker WL, et al. HF STATS 2024: heart failure epidemiology and outcomes statistics. An updated 2024 report from the Heart Failure Society of America. J Card Fail. 2025;31(1):66-116. https://doi.org/10.1016/j.cardfail.2024.07.001
• Chan A, Baker WL, Abazia D, et al. Impact of artificial intelligence on future clinical pharmacy research and scholarship. American College of Clinical Pharmacy commentary. J Am Coll Clin Pharm. 2025 Feb 13. [Epub ahead of print] https://doi.org/10.1002/jac5.70003
• Jaiswal A, Baker WL, Pillai A, et al. Corticosteroid use 1-year after adult heart transplantation worsens outcomes: a contemporary analysis of the ISHLT registry. J Heart Lung Transplant Open. 2025;8C:100214. https://doi.org/10.1016/j.jhlto.2025.100214
• Jedeon Z, Pillai A, Baker WL, Jaiswal A. Donor pulmonary hemodynamics does not impact recipient outcomes in adult heart transplantation. Int J Cardiol. 2025;420:132747. https://doi.org/10.1016/j.ijcard.2024.132747
• Virrueta NA, Valdiviez V, Beutel T, Titus OJ, Peauroi S, Billups SJ. Pharmacist-supported electronic outreach to address medication nonadherence in Medicare Advantage enrollees. J Manag Care Spec Pharm. 2025;31(1):33-41. https://doi.org/10.18553/jmcp.2025.31.1.33
• Covvey JR, Guarascio AJ. Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex. Exp Rev Anti Infect Ther. 2024;22(11):925-934. https://doi.org/10.1080/14787210.2024.2400703
• Gionfriddo MR, McClendon C, Nolfi DA, Kalarchian MA, Covvey JR. The importance of rigor in pharmacy research: challenges and solutions. Res Social Adm Pharm. 2025 Feb 7. [Epub ahead of print] https://doi.org/10.1016/j.sapharm.2025.02.005
• Gionfriddo MR, Owens K, Banks H, Sherigar A, Covvey JR. An analysis of national news coverage of semaglutide for weight loss. J Am Pharm Assoc. 2024;65(1):102297. https://doi.org/10.1016/j.japh.2024.102297
• Sifontis NM, Connor SE, Ho JAC, Morley S, O’Brien CE, Rotzenberg K, Varadarajan R, Covvey JR. A modified Delphi process to achieve consensus on social/administrative science topics in the pharmacy curriculum. Am J Pharm Educ. 2025;89(2):101349. https://doi.org/10.1016/j.ajpe.2024.101349
• Vordenberg SE, Irwin AN, Mai Y, Hamper JG, Gionfriddo MR, Hohmeier KC, Covvey JR. Laying the foundation for success: a guide to pharmacy residency research projects. J Am Pharm Assoc. 2025 Feb 14. [Epub ahead of print] https://doi.org/10.1016/j.japh.2025.102358
• Wasserman RL, Edrees HH, Amato MG, Seger DL, Frits ML, Hwang AY, et al. Frequency and preventability of adverse drug events in the outpatient setting. BMJ Qual Saf. 2024 Jul 9. [Epub ahead of print] https://doi.org/10.1136/bmjqs-2024-017098
• Wasserman RL, Seger DL, Amato MG, Hwang AY, Fiskio J, Bates DW. A calculated risk: evaluation of QTc drug-drug interaction (DDI) clinical decision support (CDS) alerts and performance of the Tisdale risk score calculator. Drug Saf. 2024;47(12):1235-1243. https://doi.org/10.1007/s40264-024-01466-w
• Mackzum C, Ambroziak R, Mullen C, Garlock J. Evaluating safety of morphine sulfate use in noncritically ill patients with acute kidney injury in the hospital setting. Am J Ther. 2024;31(5):e580-e584. https://doi.org/10.1097/MJT.0000000000001733
• Radhakrishnan Y, Patel J, Syed A, Vazquez K, Mullen CL, Cucci M. Incidence and clinical outcomes of critically ill patients with augmented renal clearance: a retrospective cohort. Nephron. 2024 Dec 9. [Epub ahead of print] https://doi.org/10.1159/000542881
• Richardson KJ, Mullen C, Sacha GL, Wasowski EM. Outcomes of hospitalized patients with sepsis before and after implementation of a sepsis care improvement initiative at a community hospital. J Pharm Technol. 2024;40(6):263-268. https://doi.org/10.1177/87551225241283193

 Presentations

• Duncan Dobbins: Emerge first: engage in research & scholarship. Presented at: MCPHS-Boston; January 2025; virtual.
• Chanda Mullen:
  • Crafting future pharmacist research heroes: a framework for building research capacity. Presented at: OSHP Annual Meeting; November 2, 2024; Columbus, OH.
  • Development of a research traineeship to promote the advancement of pharmacist researchers. ACCP Annual Meeting; October 12-15, 2024; Phoenix, AZ.

Hematology/Oncology PRN

Publications

• Hayes SM, Preedit J. The inpatient oncology pharmacist experience in the era of temporary oncologists. J Oncol Pharm Pract. 2024;30(8):1465-1467. https://doi.org/10.1177/10781552241287715
• Dennison M, Holle L. Falls and fractures in men with prostate cancer taking second-generation androgen receptor antagonists: a retrospective chart review. J Oncol Pharm Pract. 2024 Oct 22. [Epub ahead of print] https://doi.org/10.1177/10781552241291837
• Elfakih H, LeBron A, Holle L, Shinya S. Apolo AB, Ballman KV, Sonpavde G, et al. Adjuvant pembrolizumab versus observation in muscle-invasive urothelial carcinoma. N Engl J Med. 2025;392(1):45-55. Pharmaceuticals Monthly. In press.
• Kulkarni P, Holle L, Shinya S. Amivantamab plus lazertinib in previously untreated EGFR-mutated advanced NSCLC. N Engl J Med. 2024;391(16):1486-1498. Pharmaceuticals Monthly. 2024;66(13):147-149.
• Latifi A, Yik, R, Holle L, Shinya S. Topical diclofenac for prevention of capecitabine-associated hand-foot syndrome: a double-blind randomized controlled trial. J Clin Oncol. 2024;42(15):1821-1829. Pharmaceuticals Monthly. 2024;66(8):163-165.
• Vaglivelo T, Holle L, Suzuki, S. Hochhaus A, Wang J, Kim DW, et al. Asciminib in newly diagnosed chronic myeloid leukemia. N Engl J Med. 2024;391(10):885-898. Pharmaceuticals Monthly. In press.
• Moore DC, Collela A, Douglas JS, Shlom EA, Vanderloo JP, Alabi F. Incorporating pharmacoequity in the formulary review and evaluation process: opportunities for health-system pharmacy & therapeutics committees to address health disparities and inequities. Am J Health Syst Pharm. 2024 Dec 5. [Epub ahead of print]
• Al-Samkari HT, Moore DC. A second chance for avatrombopag in chemotherapy-induced thrombocytopenia. Br J Haematol. 2025;206:375-377. https://doi.org/10.1111/bjh.19861
• Arnall J, Elmes JB, Yogarajah U, Meek B, Moore DC. Managing and mitigating discontinuation syndrome with ruxolitinib and other novel JAK inhibitors for myelofibrosis. J Hematol Oncol Pharm. 2025;15(1):36-42.
• Chan A, Baker WL, Abazia D, Bauman J, DeVane L, Goodlet KJ, Hall N, Hicks JK, Jones E, Lu CH, Moore DC, et al. Impact of artificial intelligence on future clinical pharmacy research and scholarship. J Am Coll Clin Pharm. 2024 Feb 13. [Epub ahead of print] https://doi.org/10.1002/jac5.70003
• Morse AL, Sacic H, Moore DC. Omidubicel for hematopoietic cell transplants: considerations for patients and treatment outcomes. Patient Prefer Adherence. 2024;18:2217-2223. https://doi.org/10.2147/PPA.S419253
• Peery M, Hill H, Sharps, Zaver A, Moore DC. B-cell maturation antigen-directed immunotherapies for the treatment of relapsed/refractory multiple myeloma: a review of the literature and implications for clinical practice. Ann Pharmacother. 2024 Oct 7. [Epub ahead of print] https://doi.org/10.1177/10600280241282115
• White TS, Arnall JR, Parish PC, Tolerico J, Tran T, Moore DC. Proximal complement inhibitors in paroxysmal nocturnal hemoglobinuria: an abundance of options in a rare disease. Expert Rev Hematol. 2025;18(1):5-9. https://doi.org/10.1080/17474086.2025.2449864
• Zacholski EH, Rugh S, Marshall J, Nadpara P, Moore DC. Obinutuzumab infusion-related reactions: multicenter retrospective evaluation on incidence, severity, and risk factors. J Adv Pract Oncol. 2024;15(7):437-443. https://doi.org/10.6004/jadpro.2024.15.7.2

Presentations

• Justin Arnall: Synergy in science: exploring complement inhibitors and innovative prophylactic strategies. Presented at: Collaborative presentation between ACCP’s Hematology/Oncology and Infectious Diseases PRNs; November 20, 2024; virtual.
• Katie Gatwood: Outpatient CAR-T: navigating logistics and patient care. Presented at: ASTCT Talks Podcast; October 14, 2024; virtual.
• Sarah Hayes:
  • Cardio-oncology in hematology. Presented at: International Academy for Clinical Hematology Weekly Webinar Series; February 2025; virtual.
  • Overcoming clinical and operational challenges of bispecific monoclonal antibody therapy implementation. Presented at: Minnesota Society of Health-System Pharmacists Central Chapter Fall Continuing Education Event; November 2024; Minneapolis, MN.
  • Buprenorphine in the management of cancer pain. Presented at: Minnesota Society of Health-System Pharmacists Midyear Clinical Meeting; September 2024; Minneapolis, MN.
  • Harmonizing hearts and health: bridging cardio-oncology practices in cancer care. Presented at: 2024 ACCP Annual Meeting; October 2024; Phoenix, AZ.
  • Importance of early diagnosis of immune thrombotic thrombocytopenic purpura [iTTP]. Presented at: Scientific Exchange Program Presentation sponsored by Sanofi, Inc.; September 2024; Phoenix, AZ.
  • The role of pharmacology in cardio-oncology. Presented at: Faculty for the International Cardio-Oncology Society and Global Cancer Consortium joint cardio-oncology training program for physicians; September 2024; virtual.
• Lisa M. Holle:
  • Introduction to PAN Foundation for HOPA members; October 11, 2024; virtual.
  • Cannabis goes mainstream: lessons learned. Presented at: 2024 ACCP Annual Meeting; October 12, 2024; Phoenix, AZ.
  • Clearing the air: cannabis in patients with cancer. Presented at: Northern New England Clinical Oncology Society Annual Meeting; November 2, 2024; Mount Washington, NH.
  • Recent developments in the treatment of clear cell, renal cell carcinoma: essential insights and updates for the healthcare team (Filmed Panel Discussion). December 18, 2024; virtual.
• Donald Moore:
  • Real-world incidence of infections in BCMA-targeting bi-specific antibodies in relapsed/refractory multiple myeloma. Presented at: Tandem Meeting, American Society of Transplantation & Cellular Therapy; February 2025; Honolulu, HI.
  • Treatment outcomes of monoclonal gammopathy of renal significance with novel agents. Presented at: American Society of Hematology Annual Meeting; December 9, 2024; San Diego, CA.
  • Demystifying the delivery and adverse event management of bispecific antibodies in the community setting. Presented at: American Society of Hematology Annual Meeting; December 7, 2024; San Diego, CA.
  • Dexamethasone for the management of CRS related to teclistamab in patients with relapsed/refractory multiple myeloma. Presented at: American Society of Hematology Annual Meeting; December 7, 2024; San Diego, CA.
• Farah Raheem: Treatment advancements and evidence for emerging therapies in hormone receptor-positive breast cancer. Presented at: American Society of Health-System Pharmacists Midyear 2024 Clinical Meeting and Exhibition; December 10, 2024; New Orleans, LA.

 New ACCP Fellows

• Justin Arnall
• Katie Gatwood

HIV PRN

Other Notable Achievements

• Alexis Horace and George Nawas: Appointed to the Louisiana Act 711 Expert Panel for Rules Promulgation to develop rules that are designed to contribute to the expansion of PrEP/PEP access.

Infectious Diseases PRN

Promotions

• Nardine Karam: Assistant Professor of Pharmacy Practice, Long Island University (LIU Pharmacy), Brooklyn, NY.
• Essie Samuel: Chair of Pharmacy Practice, PCOM Georgia, School of Pharmacy, Suwanee, GA.

 Awards

• Elizabeth Covington: AACP Technology in Pharmacy Education SIG Innovation Award.
• Wes Kufel:
  • 2024 Society of Infectious Diseases Pharmacists (SIDP) Outstanding Early Clinician Award.
  • 2024 Journal of the American College of Clinical Pharmacy (JACCP) Outstanding Reviewer Award.
• Cynthia Nguyen: Innovation Award. University of Chicago Medicine Department of Pharmacy.
• Katie Suda: Sustained Contributions to the Biomedical Literature, ASHP Foundation.

 Grants

• Elizabeth Covington: Investigation of Antimicrobial Resistance in Dog Urinary Pathogens: Implications for One Health. HCOP-VCOM Seed Grant ($40,000).
• Wes Kufel: Board Certification Exposure and Awareness Among United States Doctor of Pharmacy Programs. Board of Pharmacy Specialties (BPS) Research Seed Grant. Principal Investigator ($5000).

 Publications

• Abdul-Mutakabbir JC, Saunders IM, Bandali A, Ko CL, Nussbaum BB, Brown SD, Hirsch EB; on behalf of the PharmGradWishlist Leadership Team and ASHP Foundation. Development and implementation of the ASHP Midyear Travel Award to support racially and ethnically minoritized pharmacy students. Am J Health Syst Pharm. 2025;82(6):257-264. https://doi.org/10.1093/ajhp/zxae304
• Shields RK, Abbo LM, Ackley R, Aitken SL, Albrecht B, Babiker A, Cifuentes R, Claeys KC, DeSear K, Gallagher JC, Gregory E, Heil EL, Hickey C, Klatt M, Kline EG, Kubat RC, Kufel WD, Lee JH, Lepak AJ, Lim A, Ludwig JM, MacDougall C, Mathers A, McCreary EK, Moore WJ, Olson S, Oxer J, Pearson JC, Pham C, Pinargote P, Polk C, Satlin MJ, Satola SW, Shah S, Solanki YB, Tamma P, Tran TT, van Duin D, VanNatta M, Vega A, Venugopalan V, Veve MP, Wangchinda W, Witt LS, Wu J, Pogue JM; PRECEDENT Network. Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study. Lancet Infect Dis. 2024 Dec 16. [Epub ahead of print] https://doi.org/10.1016/S1473-3099(24)00648-0. Erratum in: Lancet Infect Dis. 2025;25(2):e68. https://doi.org/10.1016/S1473-3099(25)00004-0
• Nelson Z, Aslan AT, Beahm NP, Blyth M, Cappiello M, Casaus D, Dominguez F, Egbert S, Hanretty A, Khadem T, Olney K, Abdul-Azim A, Aggrey G, Anderson DT, Barosa M, Bosco M, Chahine EB, Chowdhury S, Christensen A, de Lima Corvino D, Fitzpatrick M, Fleece M, Footer B, Fox E, Ghanem B, Hamilton F, Hayes J, Jegorovic B, Jent P, Jimenez-Juarez RN, Joseph A, Kang M, Kludjian G, Kurz S, Lee RA, Lee TC, Li T, Maraolo AE, Maximos M, McDonald EG, Mehta D, Moore WJ, Nguyen CT, Papan C, Ravindra A, Spellberg B, Taylor R, Thumann A, Tong SYC, Veve M, Wilson J, Yassin A, et al. Guidelines for the prevention, diagnosis, and management of urinary tract infections in pediatrics and adults: a WikiGuidelines group consensus statement. JAMA Netw Open. 2024;7(11):e2444495. https://doi.org/10.1001/jamanetworkopen.2024.44495. Erratum in: JAMA Netw Open. 2024;7(12):e2453497. https://doi.org/10.1001/jamanetworkopen.2024.53497
• Durham SH, Covington EW, Roberts MZ, Chahine EB. Rifampin in device-related infections: assessing the modern evidence. Am J Health Syst Pharm. 2025;82(4):184-202. https://doi.org/10.1093/ajhp/zxae263
• El Nekidy WS, Al Ali M, Abidi E, El Lababidi R, Alrahmany D, Ghazi IM, Mooty M, Hijazi F, Ghosn M, Mallat J. Clinical outcomes of ceftazidime-avibactam versus ceftolozane-tazobactam in managing pseudomonal infections in patients undergoing renal replacement therapy. Antibiotics (Basel). 2024;13(8):699. https://doi.org/10.3390/antibiotics13080699
• Lee-St John TJ, Kanwar O, Abidi E, El Nekidy W, Piechowski-Jozwiak B. Towards artificial intelligence-based disease prediction algorithms that comprehensively leverage and continuously learn from real-world clinical tabular data systems. PLoS Digit Health. 2024;3(9):e0000589. https://doi.org/10.1371/journal.pdig.0000589
• Gettman L. Practicing and assessing skills of interpreting culture and sensitivity reports. CPTL Pulses Blog Post. https://pulsesrx.com/2025/01/16/practicing-and-assessing-skills-of-interpreting-culture-and-sensitivity-reports/. January 16, 2025.
• Bixby ML, Daley EC, Collins LB, Salay JM, Bryson AL, Hirsch EB. Skipped wells and scientific error during fosfomycin agar dilution and broth microdilution leads to inconsistent minimal inhibitory concentrations and may be cause for reevaluating testing methods for Klebsiella pneumoniae. Microbiol Spectr. 2024;12(8):e0420523. https://doi.org/10.1128/spectrum.04205-23
• Bixby ML, Salay J, Hirsch EB. What’s new in 2024 from the CLSI subcommittee on antimicrobial susceptibility testing. Contagion Live. October 2024. https://indd.adobe.com/view/8c275a70-0dbe-431d-935c-c9f572d6ce1b
• Karam N, Amankwah M, Gim S, Cope R. Pharmacy students’ self-reported cultural competence in a pharmacy curriculum by academic year. Am J Pharm Educ. 2024;88(11):101304. https://doi.org/10.1016/j.ajpe.2024.101304
• Kufel WD, Hanrahan KD, Seabury RW, Parsels KA, Gallagher JC, MacDougall C, Covington EW, Chahine EB, Britt RS, Steele JM. Let’s have a chat: how well does an artificial intelligence chatbot answer clinical infectious diseases pharmacotherapy questions? Open Forum Infect Dis. 2024;11(11):ofae641. https://doi.org/10.1093/ofid/ofae641
• Kufel WD, Jeffres MN, Bland CM, Jones BM, Staicu ML, Justo JA, Bookstaver PB, Avery LM. A comprehensive survey of penicillin allergy education among United States colleges and schools of pharmacy. J Am Coll Clin Pharm. 2024;7(12):1163-1171. https://doi.org/10.1002/jac5.2044
• Kufel WD, Kufel JE. Use of local treatment in managing infections: focus on antimicrobial locks, beads, and cement. Am J Health Syst Pharm. 2025;82(4):211-222. https://doi.org/10.1093/ajhp/zxae264
• Dressler A, Seabury RW, Darko W, Kufel WD, Steele JM, Kelly C, et al. Nationwide survey to characterize and compare the research experiences of American Society of Health-System Pharmacists–accredited postgraduate year one pharmacy residency programs. J Pharm Pract. 2025;38(1):128-140. https://doi.org/10.1177/08971900241273223
• Wu MS, Kufel WD, Riddell SW, Steele JM, Asiago-Reddy E. Persistent methicillin-resistant Staphylococcus aureus (MRSA) nares test positivity during initial days of systemic anti-staphylococcal antimicrobial therapy. Am J Infect Control. 2025;53(1):154-156. https://doi.org/10.1016/j.ajic.2024.08.014
• Lam H, Parsels KA, Steele JM, Kufel WD, Andrew R, Miller CD, et al. Utilization of the PEN-FAST clinical decision-making tool to update penicillin allergies and identify low-risk patients. J Pharm Pract. 2024;38(2):221-224. https://doi.org/10.1177/08971900241302394
• Mahoney MV, Hirsch EB, Wright WF. AMRrounds: Achromobacter xylosoxidans susceptibility—so it goes. JAC Antimicrob Resistance. 2024;6(5):dlae134. https://doi.org/10.1093/jacamr/dlae134
• Krzos PM, Nguyen CT, Kane B, et al. Evaluation of a ureteral stent removal protocol in adult kidney transplant recipients. Open Forum Infect Dis. 2024;11(9):ofae510. https://doi.org/10.1093/ofid/ofae510
• Pettit NN, Lew AK, Nguyen CT, Bell E, Lehmann CJ, Pisano J. Fidaxomicin versus oral vancomycin for Clostridioides difficile infection among patients at high risk for recurrence based on real-world experience. Infect Control Hosp Epidemiol. 2024;45(11):1286-1292. https://doi.org/10.1017/ice.2024.145
• Pettit NN, Nguyen CT, Lew AK, Pisano J. Impact of the sequential implementation of a pharmacy-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal-swab ordering policy and vancomycin 72-hour restriction protocol on standardized antibiotic administration ratio (SAAR) data for antibiotics used for resistant gram-positive infections. Infect Control Hosp Epidemiol. 2024;45(2):196-200. https://doi.org/10.1017/ice.2023.190
• Fields P, David C, Choksi A, Pettit NN, Lew AK, Pisano J, Nguyen CT. Curbing inappropriate C. difficile treatment in patients receiving concomitant laxatives. Antimicrob Steward Healthc Epidemiol. 2025;5(1):e50. https://doi.org/10.1017/ash.2025.25
• Samuel E, McCanless JD, Saadut Z, Wilson A, Bhut K, Vo V. Side effects of miscellaneous antibiotics. In: Ray S, ed. Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Vol 46. Elsevier; 2024:291-315. https://doi.org/10.1016/bs.seda.2024.07.016

 Presentations

• Wasim El Nekidy:
  • Clinical outcome of antimicrobial dosing in patient receiving renal replacement therapy. Presented at: The best of SCCM Critical Care Congress; October 31-November 2, 2024; Abu Dhabi, UAE.
  • Optimization of antimicrobial dosing in critically ill undergoing renal replacement therapy. Presented at: The 12th Egyptian Society of Intensive Care and Trauma (ESICT 2024) Conference; December 19-20, 2024; Cairo.
  • Precision medicine: therapeutic drug monitoring-guided dosing vs. the “one-size-fits-all” approach. Presented at: Adjunct Faculty Event, Khalifa University; Abu Dhabi, UAE.
• Betsy Hirsch:
  • Acinetobacter baumannii ad hoc working group: doxycycline breakpoints review. Presented at: Clinical and Laboratory Standards Institute Winter Meeting; January 26, 2025; Orlando, FL.
  • Implementing patient-centered activities in the clinical microbiology laboratory. Platform presentation at: Benchtop to Bedside Use of Antimicrobial-Resistance Data: Detection, Prevention, and Response to Carbapenem Resistance in SE Asia. Presented at: Thailand Applied Science Hub FY25 Workshop, Sponsored by the Centers for Disease Control and Prevention; December 11, 2024; Bangkok, Thailand.
  • Paving a pathway to optimize management of patients with CPOs: use of treatment guidelines and clinical pathways. Platform presentation at: Benchtop to Bedside Use of Antimicrobial-Resistance Data: Detection, Prevention, and Response to Carbapenem Resistance in SE Asia. Thailand Applied Science Hub FY25 Workshop, Sponsored by the Centers for Disease Control and Prevention; December 12, 2024; Bangkok, Thailand.
• Wes Kufel:
  • Therapeutic debates 2024. Safety showdown: analyzing vancomycin and piperacillin-tazobactam versus vancomycin and cefepime in antibiotic regimens. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting 2024; December 9, 2024; New Orleans, LA.
  • Management case study: development and implementation of a clinical research microcredential program for pharmacy residents. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting 2024; December 9, 2024; New Orleans, LA.
  • Let’s have a chat: How well does an artificial intelligence chatbot answer clinical infectious diseases pharmacotherapy questions? Presented at: IDWeek 2024; October 19, 2024; Los Angeles, CA.
  • Clinical management of Lyme disease and tick-borne infections. Presented at: New York State Lyme and Tick-Borne Disease Summit; September 19, 2024; Syracuse, NY.
• Essie Samuel: Making history innovative: using pharmacy history activities to support content in a variety of courses. Presented at: American Association of Colleges of Pharmacy Annual Meeting; July 2024; Boston, MA.

Other Notable Achievements

• Nardine Karam: BCIDP.

Nephrology PRN

Awards

• Wendy St. Peter: Health and Human Services Kidney X Sustainability Prize, $1,025.714; Member of SMART-PD team.

Grants

• Lauren Anderson: Faculty Research Consortium Outcomes-Based Research Fellowship Award. St. John’s University ($1500).
• Wendy St. Peter: NIDDK, United States Renal Data System Coordinating Center Contract, Hennepin Healthcare Research Institute, ID 75N94024C00001; $14,446,974 (2024-2029), Co-Investigator.

 Publications

• El Nekidy WS, Al Ali M, Abidi E, El Lababidi R, Alrahmany D, Ghazi IM, Mooty M, Hijazi F, Ghosn M, Mallat J. Clinical outcomes of ceftazidime-avibactam versus ceftolozane-tazobactam in managing pseudomonal infections in patients undergoing renal replacement therapy. Antibiotics (Basel). 2024;13(8):699. https://doi.org/10.3390/antibiotics13080699
• El Nekidy WS, Alzaman K, Abidi E, Ghosn M, Ismail K, Ghazi IM, et al. Clinical outcomes of cefepime dosing in patients with Pseudomonas aeruginosa infections undergoing renal replacement therapies. Hemodial Int. 2025 Feb 18. [Epub ahead of print] https://doi.org/10.1111/hdi.13204
• Elrefaei H, El Nekidy WS, Nasef R, Motasem M, Mkarim Y, Al Quteimat O, et al. The impact of clinical pharmacist-driven weekend antimicrobial stewardship coverage at a quaternary hospital. Antibiotics (Basel). 2024;13(10):974. https://doi.org/10.3390/antibiotics13100974
• Lee-St John TJ, Kanwar O, Abidi E, El Nekidy W, Piechowski-Jozwiak B. Towards artificial intelligence-based disease prediction algorithms that comprehensively leverage and continuously learn from real-world clinical tabular data systems. PLoS Digit Health. 2024;3(9):e0000589. https://doi.org/10.1371/journal.pdig.0000589
• Fravel MA, Ernst ME, Woods RL, Orchard SG, Polkinghorne KR, Wolfe R, et al. Effects of statins on kidney function in older adults. J Am Geriatr Soc. 2024 Dec 18. [Epub ahead of print] https://doi.org/10.1111/jgs.19319
• Bongetti E, Wolfe R, Wetmore J, Murray A, Woods R, Espinoza S, Ernst M, Fravel M, et al. Association between albuminuria and glomerular filtration rate with incident frailty. Kidney Int Rep. 2025;10(2):489-502. https://doi.org/10.1016/j.ekir.2024.11.017
• Bongetti E, Wolfe R, Wetmore JB, Murray AM, Woods RL, Fravel MA, et al. Classification of chronic kidney disease in older Australian adults by the CKD-EPI 2009 and 2021 equations: secondary analysis of ASPREE study data. Med J Aust. 2025;222(2):74-81. https://doi.org/10.5694/mja2.52559
• Ernst ME, Phan K, Nelson MR, Woods RL, Fravel MA, Beilin L, et al. Daily low-dose aspirin and blood pressure in community-dwelling older adults. J Clin Hypertens (Greenwich). 2024;26(10):1188-1195. https://doi.org/10.1111/jch.14891
• Ives A, Maes M, Sawyer K, Bergbaken J, Van Hooser J, Fravel M, et al. Charting a course: use of electronic health records in skills-based pharmacy education. J Am Coll Clin Pharm. 2024;7:1099-1106. https://doi.org/10.1002/jac5.2042
• Nguyen T, Camins BC, Butler DA. Taurolidine and heparin as catheter lock solution for central venous catheters in hemodialysis. Am J Ther. 2024;31(4):e398-409. https://doi.org/10.1097/MJT.0000000000001736
• Nguyen T, Rungkitwattanakul D. Complications of chronic kidney disease: anemia and mineral and bone disorder. In: Irons BK, Meredith AH, eds. Ambulatory Care Self-Assessment Program, 2024 Book 3. Nephrology and Dermatology Care. American College of Clinical Pharmacy; 2024:115-137.
• Nguyen T, Wang AZ. Safety of iron chelation therapies in kidney disease. NJ J Pharm. February 2025;XCIX(61):5-9.
• Nguyen T, Wong E. Aprocitentan: a novel endothelin receptor antagonist for hypertension. J Nurse Pract. 2024;20(9):105200. https://www.npjournal.org/article/S1555-4155(24)00276-9/abstract
• Cui C, Nguyen T, Rattu MA. Appropriate use of inpatient erythropoiesis stimulating agents. Innov Pharm. 2024;15(4):Article 4. https://doi.org/10.24926/iip.v15i4.6284
• Xiao D, Nguyen T. Midodrine for intradialytic hypotension. Nephrol Nurs J. 2024;51(6):549-552.
• St. Peter WL, Bzowyckyi AS, Anderson-Haag T, Awdishu L, Blackman M, Bland A, et al. Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: a consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions. Am J Health Syst Pharm. 2024 Nov 18. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae317
• St. Peter WL, Maxson R, Meaney CJ. Pharmacist-led optimal medication management is achievable in a value-based care model. Nephrol News Issues. 2024 August 12. https://www.healio.com/news/nephrology/20240807/pharmacist-led-optimal-medication-management-is-achievable-in-a-value-based-care-model
• Johansen KL, Gilbertson DT, Li S, Li S, Liu J, Roetker NS, Chertow GM, Ku E, Schulman IH, Greer RC, Chan K, Abbott KC, Butler CR, O’Hare AM, Powe NR, Reddy YNV, Snyder J, St. Peter WL, et al. US Renal Data System 2023 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2024;83(4 suppl 1):A8-A13. https://doi.org/10.1053/j.ajkd.2024.01.001
• Navaneethan SD, Bansal N, Cavanaugh KL, Chang A, Crowley S, Delgado C, Estrella MM, Ghossein C, Ikizler A, Konicki H, St. Peter W, et al. KDOQI US commentary on the KDIGO 2024 clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2025;85(2):135-176. https://doi.org/10.1053/j.ajkd.2024.08.003
• Roetker NS, Johansen KL, Wetmore J, St. Peter WL. Chapter 7: Prescription drug coverage in patients with CKD. In: US Renal Data System, USRDS 2024 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2024.
• Roetker NS, Johansen KL, Wetmore J, St. Peter WL. Chapter 10: Prescription drug coverage in patients with ESRD. In: US Renal Data System, USRDS 2024 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2024.
• Salama L, Hudmon K, Myran L, Elkhadragy N. Closing tobacco treatment gaps for rural populations: the role of clinic-based pharmacists at a federally qualified health center. Pharmacy (Basel). 2025. https://www.mdpi.com/2226-4787/13/1/10
• Salama L, Sangiovanni R. Case series: evaluation of kidney function. In: Irons BK, Meredith AH, eds. Ambulatory Care Self-Assessment Program, 2024 Book 3. Nephrology and Dermatology Care. American College of Clinical Pharmacy; 2024:93-108.
• Weltman MR, Lavenburg LU, Han Z, Alghwiri AA, Mosslemi M, Rollman BL, Fischer GS, Nolin TD, et al. Population health management and guideline-concordant care in CKD: a secondary analysis of kidney coordinated health management partnership. J Am Soc Nephrol. 2024 Nov 1. [Epub ahead of print] https://doi.org/10.1681/ASN.0000000544

Presentations

• Wasim El Nekidy:
  • Clinical outcome of antimicrobial dosing in patient receiving renal replacement therapy. Presented at: The best of SCCM Critical Care Congress; October 31-November 2, 2024; Abu Dhabi, UAE.
  • Optimization of antimicrobial dosing in critically ill undergoing renal replacement therapy. Presented at: The 12th Egyptian Society of Intensive Care and Trauma (ESICT 2024) Conference; December 19-20, 2024; Cairo.
  • Precision medicine: therapeutic drug monitoring-guided dosing vs. the “one-size-fits-all” approach. Presented at: Adjunct Faculty Event, Khalifa University; Abu Dhabi, UAE.
  • Alfacalcidol versus calcitriol in the management of secondary hyperparathyroidism in chronic kidney disease. Presented at: ASN Kidney Week; October 2024; San Diego, CA.
  • Comparative clinical outcomes of iron sucrose versus ferric carboxymaltose. Presented at: ACCP Annual Meeting; October 12-15, 2024; Phoenix, AZ.
• Michelle Fravel:
  • The association between urine albumin and estimated glomerular filtration rate with incident frailty in healthy older adults: secondary analysis of the ASPREE trial cohort. Presented at: ASN Kidney Week; November 2024; San Diego, CA.
  • Impact of the CKD-EPI 2021 equation on the classification of CKD in older Australian adults. Presented at: American Society of Nephrology Kidney Week; November 2024; San Diego, CA.
  • Performance of the American Heart Association PREVENT cardiovascular risk calculator in older adults. Poster presented at: 2024 American College of Clinical Pharmacy Annual Meeting; October 2024; Phoenix, AZ.
  • Bridging knowledge to action: practical strategies for optimal CKM syndrome care. Presented at: 2024 ACCP Annual Meeting; October 12, 2024; Phoenix, AZ.
• Timothy Nguyen:
  • The privilege and future of care for patients with kidney disease. Presented at: American Association of Kidney Patients Annual Meeting; September 26, 2024; virtual.
  • NSAIDs should be a part of the pain management armamentarium in CKD: con. Presented at: American Society of Nephrology Kidney Week; October 27, 2024; San Diego, CA.
  • Treatment of anemia of CKD: what is the role of hypoxia-inducible factor prolyl hydroxylase inhibitors? Presented at: American Society of Nephrology Kidney Week; October 25, 2024; San Diego, CA.
• Wendy St. Peter:
  • The privilege and future of care for patients with kidney disease. Presented at: American Association of Kidney Patients Annual Meeting; September 26, 2024; virtual.
  • NSAIDs should be a part of the pain management armamentarium in CKD. Presented at: American Society of Nephrology Kidney Week; October 27, 2024; San Diego, CA.
  • Treatment of anemia of CKD: what is the role of hypoxia-inducible factor prolyl hydroxylase inhibitors? Presented at: American Society of Nephrology Kidney Week; October 25, 2024; San Diego, CA.
• Lavinia Salama:
  • Evaluating dual-energy X-ray absorptiometry (DEXA) scan utilization in post-menopausal women: a quality improvement project at the University of Wyoming Family Medicine Residency Program in Cheyenne. Presented at: American Society of Health-System Pharmacists 2024 Midyear Clinical Meeting and Exhibition; December 2024; New Orleans, LA.
  • Retrospective assessment of the relationship between diabetes distress and pre-existing depression and/or anxiety diagnoses. Presented at: American Society of Health-System Pharmacists 2024 Midyear Clinical Meeting and Exhibition; December 2024; New Orleans, LA.
  • Diagnosing the overlooked: latent autoimmune diabetes in adults (LADA) in a federally qualified health center in rural Wyoming—a case series. Presented at: American Society of Health-System Pharmacists 2024 Midyear Clinical Meeting and Exhibition; December 2024; New Orleans, LA.
  • Evaluation of vitamin B12 monitoring in patients receiving metformin therapy in a federally qualified health Center (FQHC) in rural Wyoming. Presented at: American Society of Health-System Pharmacists 2024 Midyear Clinical Meeting and Exhibition; December 2024; New Orleans, LA.
  • Cardio-kidney-metabolic syndrome: how pharmacists can help de-fragment care for patients. Presented at: ASHP 2024 Midyear Clinical Meeting and Exhibition; December 2024; New Orleans, LA.

Pediatrics PRN

Grants

• Allison Chung: Lindsey W, Chung AM, Hartsell F, Loosier C, Grabowsky A. Systematic Reviews: Biologic Drugs for Nonasthma Indications—Clinical Update. Portland, OR: Center for Evidence-Based Policy, Oregon Health & Science University. ($65,700). July 2024-December 2024.

Publications

• Chung AM, Sehgal M, Gavrilita C, Falkos S, Vidal R. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in the pediatric intensive care unit: a prospective randomized, double-blind placebo controlled intervention. J Pediatr Pharmacol Ther. 2025;30(1):47-51. https://doi.org/10.5863/1551-6776-30.1.47
• Clements JN, McClendon K, Borchert J, Ciapala SRL, Courtney LA, Cummings J, Fallon JM, Fritz MK, Gibson CM, Isaacs AN, Israel EN, Johnson PN, Krauter A, Stolte AR. Teaching experiences in pharmacy residency. J Am Coll Clin Pharm. 2025;8:62-69. https://doi.org/10.1002/jac5.2066
• Hall B, Markham K. New pulmonary vein stenosis therapies. The Advocate. Pediatric Pharmacy Association, Fall 2024:10-12.
• Hall B, Steidl K. Rubrics cubed: evaluating pharmacy residency applications through rubrics. The Advocate. Pediatric Pharmacy Association, Fall 2024:18-23.
• Chenhsu RY, Hall BA, Tran H, Donnelley MA, et al. Vancomycin area under the curve to minimum inhibitory concentration ratio for treatment effectiveness in pediatric and neonatal staphylococcal infections: a systematic review. J Pediatr Pharmacol Ther. 2025;30(1):52-64. https://doi.org/10.5863/1551-6776-30.1.52
• Mnatzaganian CL, Dennehy C, Pon T, Brown M, Hall B, Sievers TM, et al. Implementation of a university-wide health-system collaborative to provide pharmacy preceptor development across multiple institutions. Am J Health Syst Pharm. 2024 Nov 18. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae348
• Huynh P, Brown A, Campisi L, Mruk A, Nguyen T, Raschka M, Afolabi T. Management of postural orthostatic tachycardia syndrome in pediatric patients: a clinical review. J Pediatr Pharmacol Ther. 2024;29(5):456-467. https://doi.org/10.5863/1551-6776-29.5.456
• Hyland SJ, Fada M, Secic M, Fada R, Lockwood MM, Parrish RH 2nd. Risk-stratified venous thromboembolism chemoprophylaxis after total joint arthroplasty: evaluation of an institutional approach. J Clin Med. 2025;14(2):366. https://doi.org/10.3390/jcm14020366
• Johnson PN, Chang E, Cormack E, Hornaday K, Neely SB, Ranallo C, et al. Detectable concentrations with inhaled tobramycin in critically ill infants and children following implementation of a standardized protocol. Ann Pharmacother. 2024 Sep 28:10600280241282433. https://doi.org/10.1177/10600280241282433
• Johnson PN, Miller JL. Peer review as a professional obligation: steps and tips to becoming a high-quality reviewer. J Pediatr Pharmacol Ther. 2024;29:570-577. https://doi.org/10.5863/1551-6776-29.6.570
• Chang E, Harkin M, Miller JL, Walsh C, Neely SB, Johnson PN. Evaluating the efficacy and safety of erythromycin for the treatment of gastroparesis in infants and children. J Pediatr Pharmacol Ther. 2025;30:70-77. https://doi.org/10.5863/1551-6776-30.1.70
• Chang E, Parman A, Johnson PN, Stephens K, Neely SB, Dasari N, Kassa N, Miller JL. Gabapentin for delirium in the neonatal intensive care unit. J Pediatr Pharmacol Ther. 2024;29:487-493. https://doi.org/10.5863/1551-6776-29.5.487
• Parman A, Johnson PN, Miller JL, Neely SB, Gupta N. Rates of stress ulcer prophylaxis deprescribing in children receiving usual versus high-dose corticosteroids in the pediatric intensive care unit with status asthmaticus. Hosp Pharm. 2024;59:677-683. https://doi.org/10.1177/00185787241267723
• Patel K, Thomson S, Vijayan M, Makoni M, Johnson PN, Stephens K, et al. Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit. Front Pediatr. 2024;12:1-8. https://doi.org/10.3389/fped.2024.1465785
• Ropp DL, Johnson PN, Stephens K, Neely SB, Chaaban H, Miller JL. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. J Perinatol. 2024;44(10):1478-1484. https://doi.org/10.1038/s41372-024-02085-0
• Zelniceck TD, Vijayarajah S, Miller JL, Johnson PN. A case series and review of literature describing the use of midodrine for vasopressor effects in pediatric patients with congenital heart disease. Hosp Pharm. 2024;59(5):544-551. https://doi.org/10.1177/001857872412427
• Sohn C, Roberts J, Jean-Jacques E, Parrish RH 2nd. A causal model for predicting the impact of pharmacotherapy on colorectal surgery outcomes. World J Surg. 2024;48(12):2831-2842. https://doi.org/10.1002/wjs.12387
• Lefchak B, Morgan D, Finch M, Madhok M, Raschka M. Ketorolac dose ceiling effect for pediatric headache in the emergency department. J Pediatr Pharmacol Ther. 2024;29(5):494-500. https://doi:10.5863/1551-6776-29.5.494
• Sampson DE, Tibesar R, Tibesar M, Finch M, Rabusch S, Raschka M. Liposomal bupivacaine for additional analgesia at iliac crest donor site in alveolar bone graft surgery: a retrospective pilot study. Cleft Palate Craniofac J. 2025 Feb 2. [Epub ahead of print] https://doi.org/10.1177/10556656251317600

Presentations

• Brent Hall:
  • Come one, come all: development of a multi-site preceptor development program. Presented at: American Society of Health-System Pharmacy National Preceptor Conference; October 3, 2024; virtual.
  • It’s so hard to say goodbye: how to survive the early separation process. Presented at: American Society of Health-System Pharmacy National Preceptor Conference; October 2, 2024; virtual.
• Ingrid Pan:
  • Leveraging biologics: treatment advances in the management of childhood-onset systemic lupus erythematosus. Presented at: 2024 ACCP Annual Meeting; October 2024; Phoenix, AZ.
  • Leveraging biologics: treatment advances in the management of childhood-onset systemic lupus erythematosus. Presented at: 2024 American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2024; New Orleans, LA.
  • Medication management: episode II—attack of the clones. Presented at: 2024 Rheumatology Advanced Practice Providers Conference; September 2024; Nashville, TN.
  • Pediatric rheumatology basics for the novice APP: juvenile idiopathic arthritis and periodic fever and autoinflammatory syndromes. Presented at: 2024 Rheumatology Advanced Practice Providers Conference; September 2024; Nashville, TN.
  • Pediatric rheumatology basics for the novice APP: systemic lupus erythematous and juvenile dermatomyositis. Presented at: 2024 Rheumatology Advanced Practice Providers Conference; September 2024; Nashville, TN.

Other Notable Achievements

• Ingrid Pan: Leadership position: Colorado Department of Regulatory Agencies Division of Insurance—Prescription Drug Affordability Advisory Council member.
• Richard H. Parrish:
  • Medicaid provider, Commonwealth of Pennsylvania.
  • Perioperative Care PRN award; has been named the “Richard H. Parrish Lifetime Achievement Award” to recognize a career-long contribution to perioperative care and the PRN.

Perioperative Care PRN

Promotions

• Michelle Dansby: Pharmacy Operations Manager, Self Regional Healthcare.

Awards

• William E. Dager: Richard H. Parrish II Lifetime Achievement Award.

 Publications

• Ebitt LM, Kassel LE, McKenzie JJ, Palm NM, Smith AN. The pharmacist’s role in optimizing medication management before, during, and after minimally invasive bariatric surgery. Am J Health Syst Pharm. 2024; 81(22):1124-1135. https://doi.org/10.1093/ajhp/zxae111
• Hyland SJ, Eaton RE, Max ME, et al. Pharmacotherapy of acute ST-elevation myocardial infarction and the pharmacist’s role, part 1: patient presentation through revascularization. Am J Health Syst Pharm. 2024 Oct 25. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae303
• Hyland SJ, Fada MJ, Secic M, Fada RA, Lockhart MM, Parrish RH 2nd. Risk-stratified venous thromboembolism chemoprophylaxis after total joint arthroplasty: evaluation of an institutional approach. J Clin Med. 2025;14(2):366. https://doi.org/10.3390/jcm14020366
• Hyland SJ, Max ME, Eaton RE, et al. Pharmacotherapy of acute ST-elevation myocardial infarction and the pharmacist’s role, part 2: complications, postrevascularization care, and quality improvement. Am J Health Syst Pharm. 2024 Oct 25. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae310
• Linn DD, Renew JR. Neuromuscular monitoring: a tutorial for pharmacists. Am J Health Syst Pharm. 2025; 82(5):e242-e251. https://doi.org/10.1093/ajhp/zxae287
• Isaacs AN, Linn DD, Saum LM, et al. Prospective evaluation of a residency preparation checklist for PGY1 match success. Am J Health Syst Pharm. 2024 Dec 9. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae354
• Blankenship CR, Betthauser KD, Hencken LN, Maamari JA, et al. Clinical response to third-line angiotensin-II vs epinephrine in septic shock: a propensity-matched cohort study. Ann Pharmacother. 2024;58(10):1003-1012. https://doi.org/10.1177/10600280231226132
• Sohn C, Roberts J, Jean-Jacques E, Parrish RH 2nd. A causal model for predicting the impact of pharmacotherapy on colorectal surgery outcomes. World J Surg. 2024;48(12):2831-2842. https://doi.org/10.1002/wjs.12387
• Wolfe RC. Perioperative implications of glucagon-like peptide-1 receptor agonists. J Perianesth Nurs. 2024;39(6):1108-1110. https://doi.org/10.1016/j.jopan.2024.09.022
• Aljundi AM, Wolfe RC. Hyperthermic intraperitoneal chemotherapy. J Perianesth Nurs. 2024;39(4):688-691. https://doi.org/10.1016/j.jopan.2024.05.016

 Presentations

• Laura Ebbitt:
  • Leveraging electronic medical records and preoperative clinics to mitigate risks associated with SGLT-2 inhibitors and GLP-1 agonists in the perioperative setting. Presented at: Society of Critical Care Medicine Annual Congress; February 23-25, 2025; Orlando, FL.
  • Trading leeches for intradermal bivalirudin for threatened free flaps. Presented at: Society of Critical Care Medicine Annual Congress; February 23-25, 2025; Orlando, FL.
  • Thrombocytopenia with concomitant CRRT: heparin allergy or HIT the brakes? Presented at: Society of Critical Care Medicine Annual Congress; February 23-25, 2025; Orlando, FL.
• Rachel Wolfe: The ABCs of MICs: interpreting minimum inhibitory concentrations and antibiotic breakpoints. Presented at: Society of Critical Care Medicine Annual Congress; February 23-25, 2025; Orlando, FL.

 New ACCP Fellows

• Molly Droege
• Sara J. Hyland
• Rachel Wolfe

Other Notable Achievements

• Laura Ebbitt: Fellow, American College of Critical Care Medicine.
• Richard H. Parrish:
  • Medicaid provider, Commonwealth of Pennsylvania.
  • Perioperative Care PRN award; has been named the “Richard H. Parrish II Lifetime Achievement Award” to recognize a career-long contribution to perioperative care and the PRN.
• Janice Tsui: Invited by ASHP to be an author/faculty for the Diabetic Ketoacidosis chapter in the new ASHP Critical Care Certificate.

Pharmacokinetics/Pharmacodynamics/Pharmacogenomics PRN

Awards

• D. Max Smith: STRIPE Double Helix Award: Excellence in Advancing Pharmacogenomics Through Collaboration.

Grants

• Shayna R. Killam: Ensuring Equity in Pharmacogenetics for Rural and Underserved Communities. Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship, National Human Genome Research Institute. Primary Investigator.

Publications

• Brown JT, Goldwire M, Massmann A, Van Heukelom J, Pasternak AL, Petry NJ, Paetznick C, Cavallari LA. The impact of pharmacogenomics on a pharmacy and therapeutic committee’s formulary system management: an opinion of the Pharmacokinetics/Pharmacodynamics/Pharmacogenomics Practice and Research Network for the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2025;8(1):52-61. https://doi.org/10.1002/jac5.2057
• Gong L, Klein CJ, Caudle KE, Moyer AM, Scott SA, Whirl-Carrillo M, et al; ClinGen Pharmacogenomics Working Group (PGxWG). Integrating pharmacogenomics into the broader construct of genomic medicine: efforts by the ClinGen Pharmacogenomics Working Group (PGxWG). Clin Chem. 2025;71(1):36-44. https://doi.org/10.1093/clinchem/hvae181
• Moore C, Williams E, Dyas R, Halman A, Stenta T, Khatri D, Elliott DA, Lange PW, Caudle KE, et al. CYP2D6 genotype and associated 5-HT3 receptor antagonist outcomes: a systematic review and meta-analysis. Clin Transl Sci. 2025;18(2):e70108. https://doi.org/10.1111/cts.70108
• Cavallari LH, Hicks JK, Patel JN, Elchynski AL, Smith DM, Bargal SA, Fleck A, Aquilante CL, Killam SR, Lemke L, Ochi T, Ramsey LB, Haidar CE, Ho T, El Rouby N, Monte AA, Allen JD, Beitelshees AL, Bishop JR, Bousman C, Campbell R, Cicali EJ, Cook KJ, Duong B, Tsermpini EE, Girdwood ST, Gregornik DB, Grimsrud KN, Lamb N, Lee JC, Lopez RO, Mazhindu TA, Morris SA, Nagy M, Nguyen J, Pasternak AL, Petry N, van Schaik RHN, Schultz A, Skaar TC, Al Alshaykh H, Stevenson JM, Stone RM, Tran NK, Tuteja S, Woodahl EL, Yuan LC, Lee CR. The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation. Pharmacogenet Genomics. 2025;35(1):1-11. https://doi.org/10.1097/FPC.0000000000000547
• Donnelly RS, Cavallari LH, McCune JS, Trofe-Clark J, Formea CM, Hoffecker G, Csere MM, Anderson KC, Bhat S, Mosley SA, Ma Q, Ferdock A, Hoffman JM, Hicks JK, Caudle KE. Decoding pharmacogenomic test interpretation and application to patient care. J Am Coll Clin Pharm. 2024;7(6):581-588. https://doi.org/10.1002/jac5.1958
• Maillard M, Nguyen JQ, Yang W, Hoshitsuki K, Relling MV, Caudle KE, Crews KR, Jeha S, Inaba H, Pui CH, Bhatia S, Karol SE, Antillon-Klussmann FG, Haidar CE, et al. Clinical actionability of the NUDT15 *4 (p.R139H) allele and its association with Hispanic ethnicity. Clin Pharmacol Ther. 2025;117(3):724-731. https://doi.org/10.1002/cpt.3501
• Smith DM, Beyene R, Kolm P, Young TA, Zifa S, Natividad V, et al. A randomized hybrid-effectiveness trial comparing pharmacogenomics (PGx) to standard care: the PGx Applied to Chronic Pain Treatment in Primary Care (PGx-ACT) trial. Clin Transl Sci. 2025;18(2):e70154. https://doi.org/10.1111/cts.70154
• Smith DM, Ho TT, Aquilante CL, Cicali EJ, El Rouby N, Hertz DL, Imanirad I, Patel JN, Scott SA, Swain SM, Tuteja S, Hicks JK. A guide for implementing DPYD genotyping for systemic fluoropyrimidines into clinical practice. Clin Pharmacol Ther. 2025 Jan 31. [Epub ahead of print] https://doi.org/10.1002/cpt.3567
• Smith DM, Schlam I, Peer C, Sissung T, Schmidt KT, Tan M, et al. Pharmacokinetics and pharmacogenomics of ribociclib in Black patients with metastatic breast cancer the LEANORA study. NPJ Breast Cancer. 2024;10(1):84. https://doi.org/10.1038/s41523-024-00692-w
• Massmann A, Heukelom JV, Weaver M, et al. Evaluation of pharmacogenetic automated clinical decision support for clopidogrel. Pharmacogenomics. 2024;25(8-9):391-399. https://doi.org/10.1080/14622416.2024.2394014
• Massmann A, Petry N, Mills S, Adjekum A, Van Heukelom J. Impact of using dosing criteria to refine pharmacogenomic clinical decision support for tricyclic antidepressants. Am J Health Syst Pharm. 2024 Nov. 9. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae337
• Pasternak AL, Zimmerman C, Park JM. Establishing a CYP3A5-genotype-guided tacrolimus dosing protocol in adult kidney transplant recipients. Am J Health Syst Pharm. In press.
• Wang J, Pasternak AL, Maggo S, Mindanao R, Nguyen JQ, Gong CL. CYP3A5 pharmacogenetic testing for tacrolimus in pediatric heart transplant patients: a budget impact analysis. Pharmacogenet Genomics. 2025;35(2):81-86. https://doi.org/10.1097/FPC.0000000000000549
• Petry NJ, Van Heukelom J, Schultz AJ, Jacobsen K, Baye JF, Mills S, Figueroa DM, Massmann A. Implementation of CYP2C19 and CYP2D6 genotyping to guide antidepressant use in a large rural health system. Am J Health Syst Pharm. 2024;81(16):723-732. https://doi.org/10.1093/ajhp/zxae083

Other Notable Achievements

• Kelly Caudle: Web of Science Highly Cited Researcher 2024 (highly cited papers that ranked in the top 1% in 2023 in the field of Pharmacology and Toxicology).

Pulmonary PRN

Promotions and Job Updates

• Jeffrey Gonzales: Ambulatory and Population Health Clinical Pharmacy Specialist, Trinity Health Mid-Atlantic.
• Jacqueline Marinac: Executive MSL, Respiratory Division, Chiesi-USA.

Awards

• Gary Milavetz: 2024 Alumni Achievement Award, The University of Minnesota College of Pharmacy.

Publications

• Boylan PM, Santibañez M, Thomas J, Weeda E, Noel ZR, Caballero J. Cannabinoids for obstructive sleep apnea: a systematic review. Pharmacotherapy. 2024;44(11):880-891. https://doi.org/10.1002/phar.4622
• Foote DC, Miller JL, Skrepnek GH, Neely S, Bennett K, Boylan PM. Montelukast deprescribing in outpatient specialty clinics: a single center cross-sectional study. Explor Res Clin Soc Pharm. 2024;16:100509. https://doi.org/10.1016/j.rcsop.2024.100509
• Young J, Spisany T, Guidry C, Hong J, Le J, El Rassi E, Boylan P. Dupilumab for chronic obstructive pulmonary disease: a systematic review. Biologics (Basel). 2025;5(1):5. https://doi.org/10.3390/biologics5010005
• Belmonte L, Fleischman M, Hinz R, Wendland E. Evaluation of cystic fibrosis medication adherence and barriers in 2020 and 2022. Clin Res Pulmonol. 2024;10(1):1068. https://doi.org/10.47739/2333-6625/1068
• Santibañez M, Boylan PM, Paloucek F, Caballero J. The social media “expert” phenomenon: need for increased pharmacy practice transparency. Front Commun (Lausanne). 2024;9:1467468.

Presentations

• Megan Fleischman: Priming migraine management: establishing a solid foundation in pathophysiology, etiology, and abortive therapy. Presented at: 2024 ACCP Annual Meeting; October 15, 2024; Phoenix, AZ.
• Jeffrey Gonzales:
  • Getting to the heart of the matter: diagnosis and stratification in pulmonary hypertension (moderator). Presented at: 2024 ACCP Annual Meeting; October 14, 2024; Phoenix, AZ.
  • Incretin hormones: novel uses but at what cost? Presented at: Placebo, LLC; November 2024; Conshohocken, PA.
  • The Medicare alphabet soup of drug costs: why is it so complicated? Presented at: Local health system to nurses, social workers and community health workers; November 2024; virtual.
  • From hospital to home: bridging the gaps in care transitions: complex heart failure patient case. Presented at: Grand Rounds for continuing education to providers, pharmacists, pharmacy technicians, and nurses; November 2024; Philadelphia, PA.
• Zach R. Smith: Getting to the heart of the matter: diagnosis and stratification in pulmonary hypertension. Presented at: 2024 ACCP Annual Meeting; October 14, 2024; Phoenix, AZ.

Other Notable Achievements

• Megan Fleischman: Accepted into 2025 ACCP Leadership Development Program.
• Jeffrey Gonzales:
  • HF-Cert from HFSA.
  • Elected Member-at-Large for Transitions of Care Community within APhA.
  • Accepted into 2025 ACCP Leadership Development Program.
• Melissa Lipari: Accepted into 2025 ACCP Leadership Development Program.
• Melissa Santibañez: 2024 Graduate of ACCP Leadership Development Program.

Transplant PRN

Grants

• Erik Henricksen: International Society for Heart & Lung Transplantation Travel Grant Award.

Publications

• Lichvar A, Park JM, Alvey N, Feist A, Pierce DR, et al. Association between burnout and workplace climate in transplant clinical pharmacists. Am J Health Syst Pharm. 2024 Nov 23. [Epub ahead of print] https://doi.org/10.1093/ajhp/zxae306
• Ho K, Cohen E, Do V, Girone G, Marvin J, Belfield K. Evaluation of transplant pharmacist-led post-transplant hyperglycemia service. J Am Coll Clin Pharm. 2025;8(2):108-115. https://doi.org/10.1002/jac5.2073
• Kopfman M, Brokhof M, Patel S, Fu D, Olaitan O. High intrapatient tacrolimus variability and increased cell-free DNA in kidney transplant recipients. Prog Transplant. 2024;34(4):204-210. https://doi.org/10.1177/15269248241288559
• He KD, Nguyen L, Norris M, Malat G, Witek S, Sammons C, Forte A, Claridge T, Clark JT, et al. Alternative Pneumocystis pneumonia prophylaxis in solid organ transplants. Transpl Infect Dis. 2025;27(1):e14410. https://doi.org/10.1111/tid.14410
• Goodlet KJ, Garcia R, Nailor MD. Universal azole prophylaxis for prevention of coccidioidomycosis among lung transplant recipients transferring care to a center within a highly endemic region. Transpl Infect Dis. 2025;27:e14379. https://doi.org/10.1111/tid.14379
• Henricksen EJ, Wayda B, Teuteberg JJ, et al. Trends in heart transplant outcomes for patients over the age of 70 years in the United States: an analysis of the scientific registry of transplant recipients database. J Heart Lung Transplant. 2025;44(1):75-81. https://doi.org/10.1016/j.healun.2024.08.001
• He KD, Nguyen L, Norris M, Malat G, Shalaby C, Sammons C, Blumberg E, Trofe-Clark J. Evaluating adverse effects of dapsone in solid organ transplants. Transpl Infect Dis. 2025 Feb 18. [Epub ahead of print] https://doi.org/10.1111/tid.70001

Presentations

• Stephanie Marie Yasechko: Rx reimagined—simplifying medications to streamline complications and discharge. Presented at: International Society for Heart & Lung Transplantation; November 19, 2024; virtual.

Other Notable Achievements

• Kellie Goodlet: Accepted into the ACCP Professional Leadership Development Program (2024-2025 cohort).

Women’s Health PRN

Promotions

• Tyler Kennedy: Clinical Pharmacist Specialist in Maternal Fetal Medicine, Barnes-Jewish Hospital, St. Louis, MO.

Awards

• Sarah Kain (as pharmacist at the COPD clinic). Awarded to Community Health Network COPD Clinic. Indianapolis Coalition for Patient Safety (ICPS) Patient Safety Hero Award. 2024 ICPS Annual Meeting.

Publications

• Cieri-Hutcherson NE, Hutcherson TC, Bradley E, Rizk J, Steele N. Mixed-methods systematic review of pharmacist-administered injectable contraception: insights from patients, pharmacists, and other healthcare professionals. J Am Pharm Assoc (2003). 2025 Feb 15. [Epub ahead of print] https://doi.org/10.1016/j.japh.2025.102360
• Hutcherson TC, Cieri-Hutcherson NE, Grosshans M, Freemire J, Meegan E, Zu V, Tal E. Systematic review of intrauterine contraceptive use and the development of toxic shock syndrome. J Pharm Pract. 2025 Jan 8. [Epub ahead of print] https://doi.org/10.1177/08971900241313402
• Hutcherson TC, Rowlee P, Abeles J, Cieri-Hutcherson NE. Systematic review of emergency department management of vaso-occlusive episodes in adults with sickle cell disease. J Sickle Cell Dis Res. 2025;2(1):yoaf001. https://doi.org/10.1093/jscdis/yoaf001
• Finks SW, Benavides D, Martin AG, Carmon AS. Real world observations of using compounded GLP-1 ± GIP agonists within a clinical pharmacist-managed cardiometabolic clinic. J Am Coll Clin Pharm. 2025;8(2):91-97. https://doi.org/10.1002/jac5.2071
• O’Connell MB, DeLellis T. Musculoskeletal and connective tissue. In: Sleeper R, Hutchinson L, eds. Fundamentals of Geriatric Pharmacotherapy: An Evidence-Based Approach. 3rd ed. American Society of Health-System Pharmacists; 2025:483-526.
• Marcath M, Craig K, O’Connell MB. Impact of #PlanA reproductive health seminars on college students’ contraception and safe sex knowledge and behaviors. Pharmacy. 2025;13:39. https://doi.org/10.3390/pharmacy13020039

 Presentations

• Nicole Campbell:
  • Toolkit for contraceptive care: a guide to hormonal contraceptives. Presented at: Seton Hall University College of Nursing’s APN Pharmacology Course; March 2025; Nutley, NJ.
  • Advancing medication safety: key updates from ISMP’s best practices 2024-2025. Presented at: 2025 Joint March Conferences presented by NJPhA and GSPO; March 2025; Florham Park, NJ.
• Nicole E. Cieri-Hutcherson:
  • Pharmacist-dispensed self-administered hormonal contraception in New York State. Presented at: Pharmacists Association of Western New York; November 6, 2024; Buffalo, NY; virtual.
  • Comprehensive contraceptive care act. New York Birth Control Access Project; November 5, 2024.
  • Pharmacist dispensing of self-administered hormonal contraceptives pursuant to the New York State standing order. Presented at: University at Buffalo School of Pharmacy; September 2024; virtual.
  • Empowering choice: how pharmacist-prescribed contraception is changing access to birth control. Co-presented with Veronica Vernon. Presented at: American Pharmacists Association; November 14, 2024; virtual.
  • Incorporating equitable and inclusive practices into gender-based health across the lifespan: menopause and postmenopausal care. Presented at: 2024 ACCP Annual Meeting; October 15, 2024; Phoenix, AZ.
• Sarah Kain:
  • Medication safety strategies in weight management. Presented at: Midwest Medication Safety Symposium; September 2024; Indianapolis, IN.
  • Navigating drug shortages in primary care. Presented at: Midwest Medication Safety Symposium; September 2024; Indianapolis, IN.
  • Lowe S, Yu B, Kain S (presenter), Sciacca N. A retrospective study of obesity and overweight treatment and outcomes in primary care. Presented at: 2024 ACCP Annual Meeting; October 2024; Phoenix, AZ.
  • VonDielinen A (presenter), Robeson K (presenter), Dermody M, Kain S, Cochran K. Effect of Vitalograph aerosol inhalation monitor implementation on a multidisciplinary chronic obstructive pulmonary disease clinic. Presented at: American Society of Health-System Pharmacists 2024 Midyear Clinical Meeting and Exhibition; December 2024; New Orleans, LA.
• Women’s Health PRN collaborated with MotherToBaby/OTIS for a 3-part webinar series:
  • Stone R. What is MotherToBaby? How clinicians can use it and teach it.
  • Stallman C, Maes M. Hot topics in drugs in pregnancy & lactation: clinical cases.
  • Ashfaq M, Pannuto-Leader L, Chambers C. Drugs in pregnancy and lactation research & how to get involved.

Other Notable Achievements

• Nicole Cieri-Hutcherson: Elected President-Elect of the New York State Council of Health-System Pharmacists.
• Lauren Cirrincione: Plenary speaker, British Pharmacological Society Annual Meeting; December 2024; Harrogate, UK.
• Shannon Finks: Became a Menopause Society Certified Practitioner (MSCP).
• Sarah Kain: Selected for the ACCP Professional Leadership Development Program.
• Marina Maes: Selected for the ACCP Professional Leadership Development Program.